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Mixtures of interacting microbes, or microbial consortia, may be a key part of the 
solution to overcoming current environmental and technological challenges, such as a 
dearth of renewable fuel sources. Microbial consortia have various advantages over 
single species, or “superbugs”, such as efficiency, robustness, and modularity. The goal 
of this dissertation is to develop tools for making use of microbial consortia and to 
demonstrate their utility through practical applications. Specifically, our efforts in 
technology development and application include: a tunable, programmable cross-feeding 
circuit; production of isobutanol (a next-generation biofuel); and sensing/screening of 
metabolite secretion. 
First, we designed and constructed a programmable genetic circuit based on 
engineered symbiosis between two E. coli auxotrophs. By regulating and tuning the 
export or production of the cross-fed metabolites we were able to tune the exchanges and 
achieve a wide range of growth rates and strain ratios. In addition, we created two-
dimensional design space plots by inverting the relationship of growth/ratio vs. inducer 
concentrations. Using the plots, we could “program” the co-culture for pre-specified 
outcomes. This proof-of-concept circuit can be applied to more complex systems where 
precise tuning of the consortium would facilitate the optimization of specific objectives. 
Next, we engineered a consortium of E. coli specialist strains fermenting either 
hexose or pentose sugars into isobutanol, and demonstrated that this co-culture exhibits 
improved isobutanol production over a diauxic monoculture under several growth 
conditions. Notably, the co-culture outperformed the monoculture on an enzymatically-
hydrolyzed lignocellulosic biomass, producing up to almost 3 g/L isobutanol without 
detoxification or supplementation.  
 ix 
Lastly, we demonstrated the utility of a microbial consortium for detecting highly-
secreting L-valine (and subsequently isobutanol) production strains. We designed a 
secretor/sensor pair that can be used to detect increased L-valine secretion by the 
“secretor” via the changes in growth of the “sensor”, a fluorescently-tagged L-valine 
auxotroph. This will be part of a larger effort to develop a new method for high-
throughout screening of microbial over-production strains. 
This dissertation presents the design, construction, and/or application of three 
synthetic microbial consortia. Through tool development and biofuel applications, our 





Chapter 1  Background and Motivation 
1.1 Microbial Consortia 
Microbial consortia are groups of interacting microbial populations that can be 
found in many diverse environmental niches. Often these heterogeneous communities are 
used for the completion of complex processes such as bioremediation, wastewater 
treatment (1), or assisting mammals in food digestion (2). For example, the populations 
of microbes living in the human gastrointestinal tract (known as the gut microbiota) 
perform many important functions for their human hosts. These include harvesting 
important nutrients, synthesizing vitamins, detoxifying foreign substances, supporting the 
immune system and participating in renewal of the gut epithelium (2). Bacterial (or 
archaeal) consortia used in wastewater treatment plants provide another example that is 
relevant to humans. These microbial communities can naturally perform many of the 
tasks needed for wastewater treatment such as nitrogen or phosphorus removal (1). They 
are transported to an artificial environment but still perform the same jobs as they would 
in their native habitat. However, these individual species cannot act alone, they rely on 
each other to provide intermediates in the overall toxin degradation pathway since each 
species can usually perform only one key reaction.  In fact, the exact composition of 
microbial mixtures used for nitrogen removal is unknown -- we are only recently 
beginning to understand the complexity of the organisms involved (1).  
Microbial consortia can be grouped into two types: natural or synthetic, with a 
distinction sometimes made between engineered communities of recombinant organisms 
or engineered communities of natural organisms. Besides their use in wastewater 
treatment, undefined microbial mixtures, or “natural/engineered consortia”, have been 
harvested directly from the environment with a goal towards lignocellulosic biomass 
degradation and fuel production, as recently reviewed by Zuroff and Curtis (3). For 
example, natural microbial mixtures were harvested in soil samples from various 
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locations throughout China, then the mixtures were further enriched for degradation of 
filter paper and raw corn stover powder (RCSP) and through this enrichment up to 81% 
of the filter paper and 51% of the RCSP was broken down (4). Several uncultured 
bacterial species were identified in the culture, though it was unclear what functions each 
of the species played in the overall process. Although these natural mixtures may initially 
be better at breaking down plant cell walls, including lignin components, their utility is 
limited by a lack of genetic tools for further engineering desirable product formation and 
a lack of general knowledge about the consortia members (5). For this reason, we will 
focus on the use of synthetic microbial consortia for the remainder of this section. 
Following is a brief review of the state of the art with regard to synthetic consortia, with a 
focus on the application of such consortia to lignocellulosic biofuel production. 
Synthetic microbial consortia may have various advantages over monocultures, or 
what is commonly referred to as a “superbug”. One of the advantages of consortia is the 
ability to complete tasks that would be too difficult for one organism, such as the co-
fermentation of glucose and xylose from lignocellulosic biomass.  Eiteman and 
colleagues engineered two Escherichia coli strains to be either glucose- or xylose-
specific fermentors, and then grew them together in co-culture (6). This system was more 
robust than a single strain process; since the strains did not compete with each other for 
nutrients they were able to adapt to fluctuations in the feed composition.  This led to a 
more efficient and faster process when compared to a single-strain fermenting both of the 
sugars.   
The previous example also highlights a second advantage of synthetic consortia 
over monocultures: the ability to compartmentalize pathways in different strains so that 
they can be individually optimized without perturbing as many interactions between other 
important cellular components (7). Other advantages include the ability to simplify the 
optimization process by the division of labor – it is easier to optimize one pathway in 
each of several different organisms than multiple pathways in one organism (see 
discussion of work by Tsai et al. (8), in Section 1.2 below) – and the possibility that the 
system can be tightly controlled by external signals. Finally, members of microbial 
communities are thought to be more robust and resistant to environmental changes than 
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non-communal members, because they can rely on specialized members when faced with 
environmental stress and nutrient limitations (7).  
When designing synthetic consortia, there are different types of relationships that 
might be beneficial to engineer amongst the consortium members, such as sequential 
utilization, co-utilization of substrate, substrate transformation, and product 
transformation, and the choice of interaction will often depend on the desired substrate 
and products (Figure 1.1) (3). However, beyond the primary interaction, other control 
systems may need to be put in place to ensure the stability of a multi-member consortium, 
such as a tunable control circuit. This is much easier to control with recombinant 
organisms rather than with natural organisms in an engineered setting due to the lack of 
tools available to modify these lesser-known organisms, as mentioned above. Therefore, 
consortia consisting of mostly recombinant organisms are likely to be the most promising 
option going forward. 
 
Figure 1.1. Model microbial symbiotic interactions based on consideration of cellular energy balances, 
adapted  from (3). 
Many interesting and recent advances in the design of synthetic consortia with 
recombinant organisms have allowed them to move beyond mimicking natural systems 
(such as a predator-prey network, (9)) to also perform specific functions, such a 
multicellular computational network (10), a synthetic mammalian clock (11), and 
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controlling biofilm formation and dispersal (12). Additionally, they have been utilized in 
various formats, ranging from microfluidic devices (9, 12-14) to inkjet printers (15).   
For example, Regot et al. (10) were able to engineer various Boolean logic gates 
and outputs from only a few inputs through the use of combinations of different 
engineered yeast cells (Figure 1.2). The cells can either respond to an external signal 
and/or a “wire” output from another yeast cell (e.g. a yeast pheromone, α factor) and then 
release either another wire or the final output, in this case green fluorescent protein 
(GFP). The various combinations could give rise to Boolean operators such as AND, N-
IMPLIES, IDENTITY, and NOT gates, and the overall computation was determined by 
the number of cells involved and the types of each engineered cell. An example of a 
three-cell combination giving rise to an OR gate is shown in Figure 1.2. By adding NaCl 
and galactose, Cell type 1 and Cell type 5 produce α factor which activates Cell type 6 to 
produce GFP. Once constructed, the cell types can be combined in various ways to make 
many types of computational outputs in a simple fashion from a small library of cells. 
They predict that with only three inputs and three cell types, more than 100 functions can 
be obtained with this library (10). This work highlights the modularity of consortia and 
their ability to perform complex functions through the combination of only a few simple 
parts. 
 
Figure 1.2 An example of an engineered multicellular OR gate using three yeast cells and two extracellular 
inputs, adapted from (10). 0.4 M NaCl and 2% galactose are added to the culture as shown in the table, and 
the resulting output GFP expression is plotted on the right. 
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In another interesting application of microbial consortia, biofilm formation and 
dispersal were controlled via quorum-sensing (QS) and engineered dispersal proteins Hha 
and BdcA expressed in two E. coli cells (a “colonizer” and a “disperser”) (12). First the 
colonizer, tagged with RFP, was seeded onto a microfluidic device. This colonizer 
contained the engineered dispersal protein BdcA under control of the QS promoter PlasI, 
and also constitutively-expressed the activator LasR. Next the dispersal cells were added 
to the device, which constitutively-expressed the 3oC12HSL (an acyl homoserine 
lactone, AHL, signal molecule) synthesis protein LasI. This molecule then bound to LasR 
in the colonizers, and activated expression of BdcA, causing removal of the colonizer 
biofilm. The GFP-tagged dispersers then remained until addition of IPTG, which induced 
expression of another dispersal protein, Hha, under control of the promoter PT5-lac. When 
grown on the device, the dispersal cells were able to replace 80% of the colonizer cells at 
44 hours, and after addition of IPTG, 92% of the disperser cells were then removed by 93 
hours (12). This work demonstrates an effective way to remove engineered biofilms, 
which are often difficult to disperse, and may have significance in clinical applications 
(12). In the next section and in Section 3.2.3, synthetic consortia are discussed with an 
application to lignocellulosic biofuel production. 
1.2 Consolidated bioprocessing for biofuel production 
A field where microbial consortia are beginning to play a larger role is in the 
production of next-generation biofuels from lignocellulosic biomass. (Further discussion 
of feedstock choices, pre-treatment options, and production strains follows in Chapter 3. 
Here we discuss the role of microbial consortia in the biofuel production process). 
Consolidated bioprocessing is a process in which cellulase and hemicellulase production, 
saccharification, and fermentation or conversion of sugars to biofuels occurs in one 
reactor and has recently been touted as promising solution to current energy issues (16, 
17). Since enzyme production contributes significantly to the overall cost of ethanol or 
other biofuel production (Figure 1.3) (16), combining this with the rest of the process 
may greatly reduce costs. Other advantages of CBP may include less cost due to reduced 
reactor volume, utilities, capital, substrate, and other raw materials. There is also a 
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possibility of higher hydrolysis rates due to synergy between the microbes and enzymes 
during production (16). 
 
Figure 1.3 Cost of ethanol production for CBP vs. separate cellulase production and simultaneous 
saccharification and co-fermentation (SSCF) (adapted from (16)).  
So far, however, no natural organism has been found that can accomplish all of 
these tasks efficiently and in industrially relevant production levels (5). Using a single- or 
multi-species, engineered or synthetic consortia, may be one way to achieve this goal. To 
illustrate the idea of enzyme-microbe synergy and modularity of synthetic consortia, a 
consortium of four yeast strains was engineered by Tsai et al. to produce three different 
cellulases as well as a scaffold protein, creating a synthetic surface-associated 
cellulosome for fermentation of ethanol from phosphoric acid-swollen cellulose (PASC) 
(Figure 1.4, (8)). In monoculture, only very low yields of ethanol had been obtained with 
a similar enzyme system, possibly due to the metabolic burden placed on the cells, but 
with this consortium approach the researchers were able to achieve yields of up to 0.475 
g ethanol/g sugar consumed (93% of theoretical yield) by leveraging the modularity of 
the system (8). Since the consortium consists of four separate strains, the ratio between 
them could be tuned to optimize the release of sugars from cellulose, and subsequently 
the production of ethanol. While this is a great example of the utility of microbial 
consortia, the feedstock used here (PASC) is often prepared in such a way as to make it 
not cost-effective for industrial-scale production (18). 
 7 
 
Figure 1.4 A synthetic yeast consortium for assembly of a synthetic cellulosome complex, adapted from 
(8). SC cells display scaffold proteins and the EC/CB, AT, and BF cells secrete cellulases.  
Another recent example of a microbial consortium used in consolidated 
bioprocessing is that of work by Bokinsky et al., who engineered two E. coli strains to 
produce either cellulases or xylanases to break down ionic liquid (IL)-treated switchgrass 
and then convert the feedstock into biofuels or fuel precursors such as butanol, pinene, 
and fatty acid ethyl esters (FAEE) (18). By engineering the E. coli to secrete heterologous 
cellulases and xylanases from species such as Clostridium stercorarium, Bacillus sp. 
D04, and Cellvibrio japonicus, and also adding in heterologous pathways for product 
formation, they were able to achieve titers of up to 71 mg/L FAEE, 28 mg/L butanol, and 
1.7 mg/L pinene without any external enzyme supplementation (18). However, this is 
only a “proof-of-concept” system at the moment, as the yields are much too low to be 
used in a commercial process, though it illustrates the promise of co-cultures in CBP 
systems for converting lignocellulosics directly into various biofuels. 
1.3 Dissertation Overview 
Our work involves engineering synthetic groups of microbial communities, or 
consortia, rather then a single microbe, or “superbug”, for use in various applications. 
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Consortia may have numerous advantages over a singular species, such as adaptability, 
modularity, and robustness. The goal of this dissertation is to demonstrate the utility and 
benefits of synthetic microbial consortia with a specific application to lignocellulosic 
biofuel production. We hope to illustrate such advantages through specific tools and 
applications: a tunable, programmable circuit; production of isobutanol (a next-
generation biofuel); and sensing/screening of metabolite secretion. 
This project will make various contributions to the current state-of-the-art, including: 
1. Demonstration of a method for controlling microbial consortia in a tunable 
manner, and for making such circuits programmable 
2. A more efficient method of producing isobutanol from lignocellulosic biomass 
(corn stover) by a two-member E. coli consortium 
3. A process for developing highly-secreting valine and isobutanol production 
strains and detection of such secretion via the use of cross-feeding auxotrophs 
 
We also discuss our major results and contributions to the field and provide future 
directions for any ongoing work. 
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Chapter 2  Design and construction of a programmable, 
synthetic E. coli consortium via tunable symbiosis 
2.1 Summary 
Synthetic microbial consortia that can mimic natural systems have the potential to 
become a powerful biotechnology for various applications. One highly desirable feature 
of these consortia is that they can be precisely regulated. In this work we designed a 
programmable, symbiotic circuit that enables continuous tuning of the growth rate and 
composition of a synthetic consortium. We developed a basic model to capture the 
dynamics of a two-member consortium based on cross-feeding, and demonstrated that the 
growth rate and composition of such a consortium could be controlled via manipulating 
the export rate of the essential metabolites. We implemented our general design through 
the exchange of tryptophan and tyrosine by two E. coli auxotrophs. By regulating the 
expression of genes related to the export of tyrosine or production of tryptophan via 
inducible promoters, we were able to tune the metabolite exchanges and achieve a wide 
range of growth rates and strain ratios. In addition, by inverting the relationship of 
growth/ratio vs. inducer concentrations to create two-dimensional design space plots, we 
were able to “program” the co-culture for pre-specified attributes with the proper addition 
of inducers indicated by the plots. This programmable proof-of-concept circuit or its 
variants can be applied to more complex systems where precise tuning of the consortium 
would facilitate the optimization of specific objectives, such as increasing the overall 
efficiency of microbial production of biofuels or pharmaceuticals. 
The majority of the work presented in the chapter has been published in PLoS ONE 
as follows: Kerner A, Park J, Williams A, Lin X. (2012)  “A Programmable Escherichia 




Genetic circuits have been used in synthetic microbial consortia to construct 
programmable patterns (20), to render various relationships among consortium members 
(9, 21, 22), and to engineer artificial biofilms (23, 24). These systems were created 
mainly to mimic and investigate the dynamics or other properties of natural consortia and 
are very well suited for this task. On the other hand, there have been few efforts on 
developing genetic circuits to enable precise tuning of microbial consortia. The capability 
of precise regulation could be a crucial property for synthetic microbial consortia in 
various applications. For example, when two hexose- and pentose-specialists are used for 
optimal utilization of hexose and pentose sugars derived from lignocellulosic biomass, 
different ratios of the two strains might be desired depending on the composition of the 
feedstock.  
In this work we have constructed a tunable, synthetic consortium of two E. coli 
auxotrophs which cross-feed and support each other when grown in co-culture. The 
ability to fine-tune this forced symbiosis is made possible via regulating the exchange of 
two amino acids (tryptophan and tyrosine) in a continuous manner. Depending on the 
amount of inducers added to the medium, we are able to obtain a wide range of growth 
rates and co-culture composition. This system is a proof-of-concept circuit that 
demonstrates the possibility of programming and tuning a synthetic microbial 
consortium. Additionally, there is evidence that mutualism may be a desirable symbiotic 
relationship for industrial processes because it may be more stable than other type of 
exchange interactions (3), and an engineered symbiosis such as the one presented here 
could help control consortium composition and ensure the prolonged existence of all 
members, as opposed to one member outcompeting slower-growing members. 
2.2.1 General scheme and basic model for two cross-feeding auxotrophs 
A general schematic of two cross-feeding, inter-dependent microbes is shown in 
Figure 2.1. In a minimal medium lacking key metabolites, these two microbes do not 
grow unless they exchange the required nutrients in an efficient manner. Previous work 
has suggested that such pair of microbes, when grown together in a batch co-culture and 
given suitable time for growth, reaches a pseudo steady state characterized by steady 
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concentrations of cross-fed metabolites and constant consortium composition (Reppas, 
Lin, et al., manuscript in preparation). Serial passaging experiments with auxotroph pairs 
indicated that this was indeed the case (data not shown).  An ODE system was formulated 
to describe the growth dynamics of a general pair of cross-feeding auxotrophs, as shown 
in Figure 2.1A. Using Monod kinetics for cell growth on a limiting nutrient, the 
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where n1 and n2 are the cell densities of the two auxotrophs (gDM/L), c1 and c2 are the  
concentrations of the cross-fed metabolites (mM), α1 and α2 are the export rates of the 
metabolites from strain 1 and strain 2 (µmol/gDM-hr), and β1 and β2 are the cellular 
requirement of strain 1 and strain 2 for the essential metabolites (µmol/gDM), 
respectively. K1 and K2 are Km values -- the concentrations (in mM) of Trp/Tyr when the 
growth rate of the W or Y strain is half of its maximal value. To model a batch co-culture 
in the minimal medium without supplementation of the cross-fed metabolites, c1 and c2 
are set to zeros as the initial condition. Computer simulation showed that given sufficient 
time, the co-culture would reach a “pseudo steady state” with two characteristics: i) the 
ratio of the two auxotrophs remains constant, which indicates that they grow at the same 
rate; and ii) concentrations of the two cross-fed metabolites remain constant. By making 
use of these conditions we can readily derive the following analytical formulae [1], [2] to 
describe the system’s growth rate, µ, and composition/ratio, r, at this pseudo steady state, 
as functions of the auxotrophs’ properties. 
                     ! = !!∙!!
!!∙!!






     [2] 
It therefore follows that at this pseudo steady state the growth rate of the co-
culture, µ, which is the same as that of each auxotroph (µ = µ1 = µ2) and the ratio of the 
two auxotrophs, r, are determined solely by the α and β parameters. At this pseudo steady 
state the two consortium members would have the same growth rate, and in addition, this 
growth rate of the co-culture and the ratio of the two microbes would be determined 
solely by each auxotroph’s export rate of its partner’s required metabolite and the 
auxotroph’s growth requirement for the metabolite it lacks. 
Based on this theoretical prediction, it should therefore be possible to control the 
co-culture growth rate and the ratio of the two microbes by manipulating either the 
auxotrophs’ export of the two cross-fed metabolites (i.e. α1 and α2) or their cellular 
requirement for the metabolites (i.e. β1 and β2). The former strategy appeared more 
straightforward so we decided to explore the usage of chemical inducers to regulate the 
synthesis and transport pathways related to the export of the two cross-fed metabolites. 
We implemented the basic scheme described above with a specific pair of tryptophan and 
tyrosine E. coli auxotrophs, W3 and Y3 (Figure 2.1B). To tune the α experimentally, 
genes related to Trp and Tyr export were cloned behind inducible promoters that can 
produce a continuous range of expression levels. The Tyr auxotroph was then tagged with 
a fluorescent protein (YFP) to allow for determination of consortium composition (see 
Methods, Section 2.3.3 for details on the composition calibration). Following is a brief 
background on the choice of targets for increased synthesis and/or export of these two 
amino acids, as well as the specific implementation of the Basic Model with the Trp/Tyr 
pair. A complete strain list is given in the Methods, Section 2.3.2, Table 2.1. 
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Figure 2.1 Basic schematic of the tunable cross-feeding circuit. (A) In this general design, inducer 1 and 
inducer 2 control the export of metabolites 1 and 2, respectively. The two auxotrophs must cross-feed in 
order to survive in the minimal medium.  (B) In our specific implementation, two E. coli auxotrophic 
strains exchange tryptophan (Trp) and tyrosine (Tyr).  The forced symbiosis is controlled by plasmids 
pAK1 (in the Trp auxotroph, W3) and pAK5 (in the Tyr auxotroph, Y3). Plasmid pAK1 contains gene 
yddG behind the tunable promoter PBAD, and pAK5 contains trpEDfbr behind PprpB (Methods). Strain Y3 is 
tagged with yellow fluorescent protein (YFP). 
2.2.2 Tryptophan and tyrosine over-production 
In order to tune the export rate (α) of either amino acid, one could manipulate the 
actual export of the molecule or attempt to overproduce the molecule, assuming that the 
extra Trp or Tyr would be exported and passed on to the partner strain. It would also be 
best to pick exporters and synthesis proteins that have a high specificity for the target 
amino acid. So far only one aromatic amino acid exporter has been identified, the inner 
membrane protein YddG which, when over-expressed in E. coli, has been shown to 
increase the export of all three aromatic amino acids from corresponding, engineered 
Phe-, Tyr-, or Trp-producers, although this may not be its primary function (25). Since 
this protein increases the amount of Tyr in the medium more than Trp (3-fold increase 
versus 1.5-fold), it was chosen for regulating the export of Tyr in strain W3. When 
studying the effect of YddG over-expression, Doroshenko et al. (2007) also knocked out 
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the function of the TyrR protein in their aromatic amino acid over-producers. TyrR is a 
transcriptional regulator with a regulon comprising at least eight transcription units, all 
having some relation to the central aromatic biosynthesis pathway or aromatic transport 
(26).  Genes in the pathway that are regulated by TyrR include: aroF, aroG, and aroL 
(see pathway in Figure 2.2 below, genes boxed).  When tyrR is knocked out, the activity 
of the aroF and aroG promoters were strongly upregulated indicating increased 
production of these enzymes (26). Due to this effect, the tyrR gene has also been knocked 
out in W3, since this may increase the carbon flux through the tyrosine pathway by up-
regulating genes upstream of tyrAB and possibly increase the chance that manipulating 
YddG production will have an effect (in our preliminary studies with YddG manipulation 
there was an insignificant effect until tyrR was knocked out). 
On the other side of the circuit, we could have tuned protein YddG in the Tyr 
auxotroph (strain Y3) as well, but the nonspecific export of Tyr and Trp is not the most 
desirable control target.  There may be some complex response resulting from the export 
of both molecules from an auxotroph that still needs one of them supplied from the 
medium. Since the over-production of Trp has been very well studied and several 
mechanisms to render pathway enzymes feedback-resistant have also been elucidated 
(27-29), we chose to control the biosynthesis of Trp and therefore its export to the W3 
strain, as no Trp-specific export protein has yet been identified. One method of Trp over-
production is to mutate the trpE gene, which encodes subunit I of the first enzyme 
complex in the Trp biosynthetic pathway, anthranilate synthase-phosphoribosyl 
transferase (AS-PT) (see Figure 2.2, genes highlighted in blue).  The AS-PT complex is a 
heterotetramer, composed of two molecules of TrpE protein and two molecules of TrpD, 
which is allosterically feedback-inhibited by Trp binding to the TrpE subunit (30). Trp 
binding to TrpE is sequential and cooperative with a hill coefficient of ~1.2, but one Trp 
molecule can inhibit the entire structure due to a conformational change that occurs when 
Trp binds (31, 32). Over-expressing a mutant TrpE protein that is unable to bind Trp, 
therefore, should confer resistance to Trp or to analogues such as 5-methyltryptophan (5-
MT). Over-expressing these feedback-resistant genes has in fact been the most popular 




Figure 2.2 Aromatic amino acid biosynthetic pathway.  Figure adapted from (29). Key abbreviations: PEP: 
phosphoenolpyruvate; E4P: erythrose 4-phosphate; DAHP: 3-deoxy-D-arobinoheptulosonate 7-phophate; 
SHIK: shikimate; S3P: shikimate 3-phosphate; CHA: chorisimate; ANTA: anthranilate; PRAA: 
phosphoribosyl anthranilate. Dotted and dashed lines indicate feedback inhibition. 
Based on this previous knowledge, a feedback-resistant mutant of anthranilate 
synthase (trpE) was chosen for over-expression and regulation. The gene construct 
trpEDfbr was commercially synthesized with the mutation S40F inserted into the trpE 
gene. The mutation S40F is an amino acid change from serine to phenylalanine at 
position 40. Caligiuri and Bauerle (1991) previously mutated plasmids carrying only the 
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S. typhimurium trpE gene to screen for feedback-resistant mutants when expressed in E. 
coli (35).  Four mutations were found that conferred a complete loss of inhibition, one of 
which was the S40F mutation. This site was also one of five sites identified for Trp 
binding in the S. marcescens TrpE subunit; the sequence of this region is conserved 
among E. coli, S. marcescens, and S. typhimurium (32). Both the trpE and trpD genes 
were included on the synthesized vector because they encode two subunits of one enzyme 
complex and we hypothesized it would be best to make sure they are at the same 
expression level in the cell by placing them both under control of an inducible promoter. 
Some studies on Trp over-production have amplified and over-expressed the entire Trp 
operon, however we did not think this was necessary since several studies over-
expressing only up to trpD or trpC have been effective (35). The mutated trpE and trpD 
genes are expressed together on the plasmid, while the natural Trp promoter will control 
the trpC-A genes on the chromosome (Figure 2.3). The Trp operon suffers from 
transcriptional attenuation by the binding of two Trp molecules to TrpR, which then 
binds to the trpL leader region, as depicted in Figure 2.3 (31, 36). If there is enough 
intracellular Trp in the Y3 strain to bind to TrpR and inhibit expression from the Trp 
promoter, trpC, trpB and trpA can still be transcribed from the internal promoter located 
in the trpD gene (36). This promoter, called trp-p2, was found to function at 1/6 the level 
of the principal trp promoter in a galactokinase assay, but still at 1/3 the level of the galP 
promoter (used as standard and considered to be a high-level promoter) (37). A map of 




Figure 2.3 Trp operon and regulatory region, modified from (38). Two molecules of Trp bind to the Trp 
operon repressor, TrpR, which then represses the Trp operon by binding to the trpL leader region (31, 36).  
2.2.3 Choosing suitable inducible promoters 
To induce and tune the above genes chosen for regulation of Trp/Tyr export, it 
would be best to choose two inducible promoters that function simultaneously and do not 
exhibit crosstalk. There are a number of inducible promoters available for use in E. coli 
but not all of them are tunable or able to produce a large expression gradient (39). After 
comprehensive review of related literature, two compatible promoters were chosen: the 
arabinose-inducible promoter PBAD and a recently created propionate-inducible promoter, 
PprpB. Unfortunately, these two promoters do suffer from catabolite repression, meaning 
that they are repressed by the glucose used as a carbon source in our minimal medium. 
However, we were still able to obtain a large gradient of expression with each promoter 
in minimal M9 medium (Figure 2.4) and did not see crosstalk when the promoters were 
used together (40, 41) (Figure 2.4).   
 
Figure 2.4 Relationship between gene expression level, measured by GFP/OD600, and inducer concentration 
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behind either the arabinose- or propionate-inducible promoters. (A) Strain W5 and (B) strain Y4. Growth 
and fluorescence data were taken from the end of exponential growth phase when the expression level was 
constant. PBAD (C) and PprpB (D) do not suffer from cross talk between the promoter and the other’s inducer 
so they can be used together in co-culture.  PprpB seems to be leakier than PBAD. The strains used were all 
tyrosine auxotrophs since only the effect of each inducer on GFP expression from the opposing promoter 
was being investigated (in this particular experiment). Strain list given in Table 2.1. 
2.2.4 Basic model implementation with E. coli strains W3 and Y3 
To adapt the basic, general model to our cross-feeding Trp and Tyr auxotrophs, 
we needed to derive an equation to capture the tuning of the export parameter, α, which is 
controlled by the two chosen inducers, arabinose and propionate. To do this we used a 
Hill function to model the effect of the inducer-activator complex binding to its 
respective promoter and inducing gene expression. The general form of this equation is 
given below [3].  From expression assays with GFP as the reporter protein (Figure 2.4), 
the best Hill coefficient for PBAD was n = 1.5 and for PprpB was n = 1. The values for the 
α0 and α1 varied according to the strain and the baseline GFP expression of the promoter. 
Here the α1 does not refer to the export from strain 1, but is a scaling factor that is 
dependent on the level of fluorescence. 
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    [3] 
The pseudo steady state total growth rate (µ) and Y3:W3 ratio (r) were plotted 
over a grid of inducer concentrations. The basic model predicts that as the inducers 
increase, the growth rate would also increase (Figure 2.5A). This is expected since 
increasing the inducer concentration increases the cross-feeding. The model also predicts 
that the highest Y3:W3 ratios will occur at high [inducer 1] and low [inducer 2], and vice 
versa (Figure 2.5B). This is also an expected result: there will be more of the Y3 strain 
when W3 is producing the most Tyr and Y3 is producing the least Trp. (Note: graph (A) 
has the origin (0,0) in front for ease of viewing, whereas graph (B) has the point (5,5) in 
front). Here we have just used generic inducers, so the units are not shown. 
Based on these simulation results, we then tested the circuit experimentally and 
saw unexpected growth dynamics, discussed in the Results section below. We further 




Figure 2.5 Basic model simulation results. Growth rate (A) and Y:W ratio (B) surface plots generated by 
varying inducer 1 and inducer 2 from 0 to 5 units. 
 
2.3 Methods 
2.3.1 Auxotroph construction and YFP addition 
A Trp auxotroph, strain W1, was constructed via P1 transduction (42) of the trpE 
gene replaced with a KanR cassette from Keio collection strain JW1469-1 (43) into wild-
type E. coli K12 MG1655. P1-facilitated gene deletion was repeated in strain W1 with 
the tyrR gene (JW1316), to obtain strain W2, a double knockout, and was also used to 
knock out the tyrA gene (JW2581) to create the Tyr auxotroph, strain Y1. The yfp gene 
was introduced into strain Y1 via the same method (host strain DS1-Y was obtained from 
the Balaban group, Hebrew University of Jerusalem) and was integrated into the intC 
locus with a cat selection cassette (strain Y2). This gene is under control of two λPR 
promoters (44). The trpE and tyrA gene knockouts were confirmed via colony PCR, as 
well as phenotypically by growing the strains alone in unsupplemented M9 medium after 
each genetic manipulation.  None of the auxotrophs grew without its partner strain (data 
not shown). 
2.3.2 Plasmid construction 
The arabinose-inducible promoter PBAD was amplified from strain BW31003 
(CGSC #8183) digested with restriction endonucleases NdeI and HindIII, and ligated to 
the pET17 expression vector (Novagen). The yddG gene was amplified from wild-type E. 
































































giving vector pAK1. This vector was transformed into the W2 strain, producing strain 
W3. The trpEDfbr gene cassette was synthesized (Geneart) and then cut with SalI and 
EcoRI and ligated to the pPro24-gfp vector behind the propionate-inducible promoter 
PprpB with GFP removed (Addgene). This vector was then transformed into strain Y2, 
giving strain Y3. Both plasmids confer ampicillin resistance.  
Table 2.1 Complete strain list for Chapter 2. 
Auxotrophy	   Name	   Genotype	   Vector	  genes	  
Tryptophan	   W1	   K12	  ΔtrpE::kanR	   /	  
	  	   W2	   K12	  ΔtrpE	  ΔtyrR::kanR	   /	  
	  	   W3	   K12	  ΔtrpE	  ΔtyrR::kanR	  pAK1	   PBAD-­‐yddG	  AmpR	  
	  	   W4	   K12	  ΔtrpE	  ΔtyrR::kanR	  pCFP	   PBAD-­‐cfp	  AmpR	  
	  	   W5	   K12	  bioA::λRed	  ΔtrpABCDE::cat	  pGFP	   PBAD-­‐gfp	  AmpR	  
Tyrosine	   Y1	   K12	  ΔtyrA::kanR	   /	  
	  	   Y2	   K12	  ΔtyrA::kanR	  intC::yfp	   /	  
	  	   Y3	   K12	  ΔtyrA::kanR	  intC::yfp	  pAK5	   PprpB-­‐trpEDfbr	  AmpR	  
	  	   Y4	   K12	  ΔtyrA::kanR	  intC::yfp	  pPro24-­‐gfp	   PprpB-­‐gfp	  AmpR	  
	   Y5	   K12	  bioA::λRed	  ΔtyrA::cat	  pGFP	   PBAD-­‐gfp	  AmpR	  
   
2.3.3 Co-culture composition determination using YFP 
Minimal M9 medium containing 0.2% glucose was used in all experiments. For 
circuit induction, either arabinose (20% w/v stock) or sodium propionate (1 M stock) was 
used at the indicated concentration. Frozen stocks were inoculated into rich LB medium 
and grown overnight to saturation. The cells were then washed and diluted by 1:800 into 
fresh minimal M9 medium and the appropriate inducers were added. Cultures were then 
pipetted onto a 96-well microplate (Grenier) to a volume of 200 µl per well. Unless 
otherwise stated, four replicates were conducted per sample. A Biotek Synergy 2 
microplate reader was used to monitor co-culture growth and composition over time via 
reading the absorbance at 600 nm and the YFP fluorescence using filters for excitation 
(485/20) and emission (528/20). For each microplate growth experiment, calibration 
between the Y3 strain OD600 and the fluorescence (FL) was obtained by plotting the FL 
vs. the OD600 and fitting the data with a linear model (see Figure 2.6 for a sample 
calibration curve). The slope was then used to determine the Y3 density in the co-culture 
(note that we could have also considered the “fluorescence” of the W3 strain, but it did 
not significantly change the results). The W3 density was obtained by subtracting the Y3 
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density from the total OD600.  The ratio Y3:W3 is then equal to the density of Y3 divided 
by the density of W3. Cultures were grown for 48 hours at 37oC with shaking and 
measurements were taken every 15 minutes. 
 
Figure 2.6 Sample YFP calibration.  Four replicates of each of K12 and Y3 were averaged, and then the 
YFP FL readout was plotted against the OD600.  The calibrations are linear during the exponential phase of 
growth, which is shown in the graph.  Excel was used to fit the data using linear regression. 
 
To validate our method for determining the co-culture composition using YFP, we 
tested four co-culture samples and compared ratio results obtained via the above method 
and differential plate counting (i.e. using viable cell counts from minimal medium petri 
dishes supplemented with Trp or Tyr). The co-cultures were grown and monitored on a 
microplate reader. Based on manual inspection of the growth curve, each co-culture was 
stopped either in the middle or at the end of exponential growth whereupon samples were 
extracted for differential plate counting (note that it is virtually impossible to continue a 
microplate growth experiment once it is stopped and the lid removed, due to technical 
complications and the risk of contamination). Out of the four tested samples, three 
showed reasonable agreement between the ratio results from the two different methods 
(Figure 2.7). In addition, we observed that when the ratio is close to one and does not 
change rapidly, the result from YFP calibration is in excellent agreement with that from 
plate counting and the error bar is very small. However, when the ratio deviates 
substantially from one and fluctuates over time (e.g. Figure 2.9B, the condition of 0.15% 
y = 77.284x - 1.3622 
R! = 0.9399 
y = 1269.5x - 5.3042 



























arabinose), the result from YFP calibration tends to be much less accurate and the error 
bar becomes much larger. 
 
Figure 2.7 Comparison of Y3:W3 ratio results determined using YFP calibration vs. plate counting. For 
each co-culture condition, four wells (replicates) were used to determine the Y3:W3 ratio using the YFP 
calibration method. After a certain period of time, the microplate reader was stopped and the four wells 
were pooled and plated on M9 minimal plates with either Trp or Tyr. Each co-culture was diluted 
appropriately to give 30 - 300 colonies per plate for accurate counting. The ratio was then calculated using 
all combinations of the Y3 cell count from Tyr+ plates and that of W3 from Trp+ plates. 
 
2.3.4 Measurement of Trp and Tyr concentrations in mono- and co-culture 
supernatants 
Concentrations of Trp and Tyr in mono- and co-cultures were estimated using a 
bioassay similar to one previously reported (21). The cultures were grown in 10 ml M9 
media in 50-ml falcon tubes. The monocultures were also supplemented with saturating 
amounts of Trp and Tyr (40 µg/ml). Inducers were added as needed. 1-ml samples were 
harvested at various time points over the course of growth corresponding to the early, 
middle and late exponential growth phases. The OD600 of the cultures was monitored over 
time to identify these points. The 1-ml samples were centrifuged at 12,000 rpm and the 
supernatants were sterile-filtered and stored at -20oC. An auxotrophic test strain, W1 or 
Y1, was grown on the sterilized culture supernatants supplemented with concentrated M9 
(400 µl supernatant and 100 µl 5X M9). The maximum OD600 reading was then used to 
determine the initial Trp or Tyr concentration in each supernatant, according to a 
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calibration curve. The Trp and Tyr calibration curves were prepared as follows. Standard 
dilutions of Trp or Tyr stocks were made with M9 media and then the corresponding 
auxotrophic test strain was grown on each standard for about 48 hours on a microplate 
reader at 37oC with shaking. OD600 measurements were taken every 15 minutes, and the 
maximum OD600 of each sample was used to generate the calibration curve.  
2.3.5 Measurement of Trp and Tyr Affinities 
Each strain (either W3 or Y3) was grown alone in M9 with specified amounts of 
Trp or Tyr at various inducer concentrations to determine the effect of the inducer on the 
strain’s affinity and maximum growth rate. More specifically, cells were first grown 
overnight in minimal M9 media with saturating amounts of Trp or Tyr (40 µg/ml). The 
cells were then washed three times in M9 and diluted to a final density of ~1000 cells/ml 
in 50 ml M9 in a 250 ml flask supplemented with the desired metabolite and inducer 
concentrations. The cultures were grown at 37oC in a shaking water bath and the initial 
growth rate was measured via plate counting. The range and spacing of sampling times 
were dependent on the expected growth rate of the culture. For each initial Trp or Tyr 
concentration, after obtaining the cell counts, the exponential growth rate and goodness 
of fit (the error bar shown at each point in Figure 2.8) were determined using Excel. 
Finally, the Matlab curve-fitting tool was used to fit each curve of growth-rate vs. 
Trp/Tyr concentration to a Monod function and to obtain the µmax and Km values. 
2.3.6 3D surface and design space plots 
Experimental 3D surface results and design spaces were plotted using MATLAB. 
For the growth and ratio results, interpolation was carried out (griddata) and the results 
were used to plot the 3D surfaces. To create the design spaces, griddata was again used to 
obtain points across a continuous space and then a closed contour plot (contourf) was 




2.4.1 Effect of inducers on metabolite secretion and growth properties of 
engineered strains   
To verify the effect of increased metabolite secretion induced by the genetic 
circuit constructed above, we performed a bioassay (21) to determine the amount of Trp 
and Tyr in W3 and Y3 monocultures. Each of these engineered strains was grown alone 
in the minimal medium with and without the corresponding inducer. The culture 
supernatants were then harvested at times corresponding to the early, middle, and late 
stages of the exponential growth phase. A test strain, either a Tyr or Trp auxotroph, was 
then grown on the sterile-filtered supernatant to determine the concentration of the 
secreted amino acid using a similarly derived calibration curve (Methods). As 
summarized in Table 2.2 and Table 2.3, we observed that, overall, addition of the inducer 
did increase the secretion of Trp or Tyr when each strain was grown in mono-culture. 
More specifically, for strain Y3, when the propionate inducer concentration was raised 
from 0 to 40 mM the amount of secreted Trp per cell at the end of exponential growth 
decreased slightly at first and then more than tripled, leading to a maximum Trp 
concentration of 142 ± 9 µg/L in the supernatant, corresponding to a culture-averaged 
secretion of 0.33 ± 0.00 µg/L/OD. Interestingly, the amount of Tyr secreted by strain W3 
was over 100 fold higher, in the range of a few to several tens of mg/L in the supernatant. 
When the arabinose inducer was added, the amount of extracellular Tyr accumulated in 
the mono-culture became so high that it was detectable starting in the early exponential 
growth phase and steadily increased both as growth proceeded and as the inducer 
concentration was raised to 0.15%, reaching concentrations > 31 mg/L, corresponding to 
a culture-averaged secretion level > 300 mg/L/OD (Table 2.2, Table 2.3). 
Table 2.2 Culture-averaged secretion of Tyr and Trp in mono-culture growth experiments. Over the course 
of growth, W3 secretes more Tyr per cell with the addition of arabinose and Y3 secretes more Trp per cell 
with the addition of NaProp. Supernatants were harvested at the early, middle stages, and the end of the 
exponential growth phase. Note the different units of Trp and Tyr (i.e. µg/L/OD vs. mg/L/OD), which 




Secreted	  Metabolite	   Culture	   Time	  point	  
	   	   middle	   end	  
Trp/OD	  [μg/L/OD]	   Y3	   N/D	   0.095	  ±	  0.002	  
	   Y3	  +	  10mM	  NaProp	   N/D	   0.063	  ±	  0.000	  
	   Y3	  +	  40mM	  NaProp	   N/D	   0.33	  ±	  0.00	  
Tyr/OD	  [mg/L/OD]	   W3	   N/D	   9.8	  ±	  0.0	  
	   W3	  +	  0.08%	  ara	   40.0	  ±	  0.0	   56.2	  ±	  0.2	  
	   W3	  +	  0.15%	  ara	   >300	   >125	  
 
In addition to the effect on metabolite secretion, it is also possible that inducing 
the genetic circuit constructed above may change the growth property of the engineered 
strains, in particular their nutrient uptake capabilities. For instance, since YddG can also 
export Trp to some degree (25), we suspected that the expression of this protein on the 
pAK1 vector may decrease its “affinity” for Trp and thereby increase the apparent Km 
value of W3 for the molecule. Therefore, for each strain, we conducted a set of flask 
experiments to evaluate the inducer’s effect on the strain’s maximum growth rate and 
affinity for its essential metabolite (described in Methods, Section 2.3.5). It was found 
that for each strain, the corresponding inducer had a negative effect on the maximum 
growth rate (Figure 2.8). In particular, the observed growth rate of W3 and Y3 decreased 
from about 0.6 1/hr to 0.2-0.3 1/hr when the inducer of arabinose or propionate was 
added. Additional experiments at saturated Trp or Tyr concentrations confirmed these 
observations, including the unusual trend that the maximum growth rate of strain W3 
decreases and then slightly recovers when the arabinose concentration increases (Figure 
2.8A and Figure 2.12).  
Subsequently, by comparing the growth of various strains at saturated Trp or Tyr 
concentrations, we found that the growth rate decrease of W3 is caused by the pAK1 
plasmid, whereas the growth of Y3 is significantly reduced due to the over-expression of 
the trpEDfbr genes on plasmid pAK5 as well as slight inhibition by the propionate 
inducer (Figure 2.12). This substantial growth decrease of the individual strains caused 
by induction of the cross-feeding circuit, termed metabolic burden, had a significant 
impact on the co-culture’s property, as will be discussed in the next section. On the other 
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hand, with the addition of inducers, the affinity parameters of the engineered strains 
appeared to have remained at comparable values, in the ranges of 2-4 µg/L Trp for W3 
and 5-8 µg/L Tyr for Y3 (Figure 2.8). 
 
Figure 2.8 Growth rates of W3 and Y3 at various Trp and Tyr concentrations. The maximum growth rates 
and affinity of W3 for Trp (A) and of Y3 for Tyr (B) were measured under inducing and non-inducing 
conditions. The Matlab curve-fitting tool was used to fit each growth curve to a Monod function and to 
obtain the µmax and Km values. The error bars at each point on the growth curve represent the goodness of 
the exponential growth curve fit. The R2 values for each Monod fit are as follows: W3 - 0%, 0.92; 0.08%, 
0.82; 0.015%, 0.87; and Y3 - 0 mM, 0.96; 20 mM, 0.88. 
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2.4.2 Changes in the consortium growth and composition 
The Trp and Tyr auxotroph pair constructed above was first grown in M9 minimal 
medium for examination of the baseline property without arabinose or propionate (Figure 
2.9). The growth rate of the co-culture, inoculated with a 1:1 strain ratio, was found to be 
0.45 ± 0.004 1/hr. To determine the ratio (Y3:W3) of the two auxotrophs, a constitutively 
expressed YFP gene was integrated into the chromosome of strain Y3. By combining 
total OD and YFP measurements, we were able to obtain the ratio of the two strains 
during growth (see Methods 2.3), however it was observed that the co-culture was not 
reaching a steady composition (Figure 2.9) as predicted by the model described in 
Section 2.2.1. This might be because the co-culture had entered the stationary phase 
before reaching the pseudo steady state. 
Further experiments revealed that the co-culture exhibits various ratio dynamics 
when the inducers are added. An example is shown in Figure 2.9, in which arabinose was 
added at different concentrations when propionate was held constant. Depending on the 
concentration of arabinose, the ratio could monotonically change to a final steady value 
or exhibit more nonlinear behavior. After observing these complex dynamics, we decided 
that instead of choosing one value to represent the co-culture “ratio” it would be better to 
examine the Y3:W3 ratio in the middle and at the end of the exponential growth phase, 
henceforth referred to as the mid-exponential and end-exponential ratios, respectively. At 
the baseline without inducers, the mid-exponential Y3:W3 ratio was found to be 0.66 ± 
0.02, and the end-exponential ratio to be about 4.41 ± 0.05. 
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Figure 2.9 Co-culture growth and ratio dynamics: baseline and with tuning. (A) Co-culture density 
(measured by OD600) and Y3:W3 ratio during growth in minimal medium without inducers. The ratio 
measurement is shown only for the exponential growth phase because the YFP calibration is not reliable 
after the cells enter the stationary phase. (B) An example of Y3:W3 ratio dynamics at various arabinose 
concentrations. Propionate concentration was held at 20 mM. Only the exponential growth phase is shown. 
Each curve represents the mean of four replicates.  Note: the secondary y-axis label in (A), Ratio Y3:W3, is 
also the label for the primary y-axis in (B). 
By simultaneously adding the two inducers that regulate the metabolic cross-
feeding circuit, we were indeed able to change the growth rate and composition of the 
synthetic consortium (Figure 2.10). Overall we achieved a fairly large range of co-culture 
growth rate (0.16 – 0.59 1/hr, Figure 2.10A), mid-exponential ratio (13 to 0.6, Figure 
2.10B), and end-exponential ratio (9.7 to 0.9, Figure 2.10C). Adding the inducers, 
however, does not affect these co-culture properties in the simple manner our basic model 
suggested. Instead, the relationship between the co-culture growth rate and inducer 
concentrations is highly nonlinear, which can be illustrated with the two edges where 
only one inducer is involved. When only arabinose is added (Figure 2.10D), increasing 
arabinose caused the co-culture growth rate to increase from 0.45 1/hr to 0.58 1/hr at 
0.08% arabinose, supposedly due to increased secretion of Tyr by strain W3 as 
demonstrated by the bioassay described in the previous section. Further increasing the 
arabinose concentration to 0.15%, unexpectedly, decreased the co-culture growth rate 
sharply to 0.20 1/hr. On the other hand, when only propionate is added, the co-culture 






















































Figure 2.10 Range of co-culture growth rate and composition regulated by two inducers. Co-culture 
experiments were conducted over a grid of inducer concentrations. The experimental results (black dots) 
were then interpolated using Matlab to create a three-dimensional surface. Range of co-culture growth rate 
(A), mid-exponential Y3:W3 ratio (B), and end-exponential Y3:W3 ratio (C) that can be achieved using 
this circuit. (D, E, F, G) Edges of the 3D surfaces. Effect of tuning arabinose and propionate on the growth 
rate (D, E) and Y3:W3 ratios (F, G). (D, F) 0mM propionate (E, G) 0% arabinose. Both the mid-
exponential and end-exponential ratio were determined using the YFP calibration. 
We also observed highly nonlinear dependence of the co-culture composition on 
inducer concentrations (Figure 2.10). Interestingly, when two edges of the 3-D plots were 
examined more closely, tuning the W3 strain through arabinose seemed to have more of 




































































































































































through propionate seemed to have more of an effect on the end-exponential ratio (Figure 
2.10G).  
The observed relationships between consortium properties (i.e. growth rate and 
strain ratio) and inducer concentrations are quite complex and nonlinear. This is likely 
due to multiple factors affecting the growth dynamics of our system, most importantly 
each inducer’s double effect of increasing metabolite secretion while decreasing growth. 
To verify the effect of regulated cross-feeding on the co-culture growth, we 
carried out two sets of negative control experiments in which the cross-feeding auxotroph 
pair was exactly the same as W3  - Y3 except that either the yddG gene in W3 or the 
trpEDfbr genes in Y3 was replaced by a negative control gene that does not participate in 
the cross-feeding circuit (i.e. CFP or GFP). It was observed that when yddG was not 
over-expressed in the tryptophan auxotroph, adding arabinose did not affect the co-
culture growth (Figure 2.11A). Furthermore, at low concentrations of arabinose, the 
negative control pair grew more slowly than the pair with the full circuit. On the other 
side, when trpEDfbr was not expressed in the tyrosine auxotroph, adding propionate 
reduced the co-culture growth rate substantially (Figure 2.11B). Notably, the pair with 
the full circuit grew faster than this negative control pair when propionate is at medium to 
high concentrations. These results indicate that tuning the target genes in the designed 
circuit is indeed regulating the cross-feeding and hence the co-culture growth. Clearly 
there is a side effect of metabolic burden from this circuit, and regulation of the co-
culture is more effective when the enhanced cross-feeding is not over-shadowed by the 
burden (for example when the arabinose concentration is not too high and propionate is at 
medium to high levels).  
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Figure 2.11 Negative control experiments. (A) Addition of arabinose has no effect on the growth rate of the 
negative tryptophan control strain (W4) and the positive tyrosine strain (Y3). (B) The growth rate of both 
cultures is decreased with the addition of increasing amounts of propionate, but the growth rate decreases 
less with the addition of the cross-feeding genes. For both (A) and (B) the negative control strain is either 
W4 or Y4.  See Table 2.1 for the complete strain genotypes. 
To understand further how the two strains W3 and Y3 interact in this co-culture, 
we also attempted to measure the amounts of Trp and Tyr in the co-culture supernatants 
at the grid “corners”, namely the arabinose and propionate concentration combinations of 
(0%, 0mM), (0.15%, 0mM),  (0%, 40mM), and (0.15%, 40mM). Using the same bioassay 
employed for the monocultures (Methods Section 2.3), we found that throughout the 
course of co-culture growth, the concentration of Trp remained below detectable levels 
(~10 µg/L) and Tyr could only be detected at the end of cultivation (~0.1 mg/L) (Table 
2.3). This was in sharp contrast to their obvious accumulation in the monocultures (Table 
2.3) and was in line with what we had initially hypothesized, i.e. that each amino acid is 
the limiting nutrient for the corresponding auxotrophic strain. Given the high affinity of 
each auxotroph for its required amino acid, with Km in the range of several µg/L (Figure 
2.8), it is very likely that the amino acid is taken up by the auxotrophic strain as soon as 
the molecule is secreted by the partner strain and hence does not accumulate in the 
supernatant. In fact, based on the observation that in a co-culture each strain’s growth rate 
was largely below its maximum value associated with the saturated amino acid 
concentration (~10 µg/L Trp for W3 and ~50 µg/L Tyr for Y3, Figure 2.8), we could 
infer that the Trp/Tyr concentrations were indeed very low, up to a few µg/L for Trp and 
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Table 2.3 Trp and Tyr concentrations in the mono- and co-culture supernatants. Trp concentrations in the 
supernatant of Y3 growing alone with either 0, 10, or 40 mM NaProp and Tyr concentrations in the 
supernatant of W3 growing alone with 0, 0.08, or 0.15% arabinose over time. No Trp was detected in the 
co-culture supernatants. *: Not detectable, below range of the calibration curve (Trp: ~10 µg/L; Tyr: ~0.1 
mg/L). **: Above range of the calibration curve, lower bound indicated. 
Secreted	  Metabolite	   Monoculture	   Time	  point	  
early	  	   middle	   end	  
Trp	  [μg/L]	   Y3	   N/D*	   N/D*	   46.9	  ±	  16.4	  
	   Y3	  +	  10mM	  NaProp	   N/D*	   N/D*	   26.4	  ±	  1.2	  
	   Y3	  +	  40mM	  NaProp	   N/D*	   N/D*	   142	  ±	  9	  
Tyr	  [mg/L]	   W3	   N/D*	   N/D*	   4.38	  ±	  0.04	  
	  	   W3	  +	  0.08%	  ara	   0.174	  ±	  0.005	   10.7	  ±	  0.2	   21.0	  ±	  2.2	  
	  	   W3	  +	  0.15%	  ara	   2.18	  ±	  0.02	   >31**	   >31**	  
Secreted	  Metabolite	   Co-­‐culture	   early	   middle	   end	  
Tyr	  [mg/L]	   (0%,	  0mM)	   N/D*	   N/D*	   1.15	  ±	  0.39	  
	   (0.15%,	  0mM)	   N/D*	   N/D*	   0.76	  ±	  0.96	  
	   (0%,	  40mM)	   N/D*	   N/D*	   0.20	  ±	  0.01	  
	   (0.15%,	  40mM)	   N/D*	   N/D*	   0.15	  ±	  0.04	  
 
2.4.3 Incorporation of metabolic burden in mathematical modeling 
Our basic model predicted that increasing the inducer concentration would 
increase the growth rate of the co-culture. We observed the opposite result 
experimentally, however, and hypothesized that the effect might be caused by the 
metabolic burden of expressing the yddG and trpEDfbr genes. In single strain growth 
experiments it was observed that increasing the amount of inducer, arabinose or sodium 
propionate (NaProp), added to either the W3 or Y3 alone, would decrease the max 
growth rate (Figure 2.12). This was also the case in the “affinity” experiments discussed 
previously (Figure 2.8). We introduced a burden term, M, which would reduce the 
maximum growth rate (µmax) giving an apparent maximum growth rate (µμmax) and would 
be based on single-strain growth data (Figure 2.12).  The general form is: 
! = ! ∙ !"# ! − ! ∙ !"# + !    [4] 
!!"# = !!"# ∙!    [5] 
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where the coefficients a, b, and c are determined from the single strain growth 
experiments shown in Figure 2.12A&C. The relationship between the maximum growth 
rate and the growth rate at a specific inducer concentration [5] was rearranged to give the 
burden, M, which was then plotted as function of the inducer concentration [4]. The 
quadratic fits are shown in Figure 2.12B&D, for the W3 strain with arabinose, and the Y3 
strain with NaProp, respectively. The control strains are either not affected, or affected to 
a lesser extent, by the inducers.  
 
Figure 2.12 Effect of arabinose and propionate on single strain growth.  (A) Arabinose (shown in % w/v) 
has a significant effect on W3, but not on W2.  The effect on the growth is not straightforward: increasing 
arabinose seems to at first have a negative effect on the growth rate, and then a slight positive effect.  (B) 
Burden effect on W3 due to YddG expression. (C) Propionate (in mM) decreases the growth rate of Y2 and 
Y4 at 20 mM.  There does not seem to be any negative effect of adding a plasmid with gfp only.  
Expressing the trpEDfbr genes has a significant negative effect on the growth rate  of Y3 even with 0 mM 
propionate and decreases sharply after addition of 5 mM propionate. (D) Burden effect on Y3 due to 
trpEDfbr expression. M = umax/umax. 
We also hypothesized that expression of the YddG protein may be affecting the W3 
strain’s affinity for Trp, since this membrane protein has also been shown to export Trp 
from the cell. As discussed previously, the Km value did not appear to change 
significantly, however we still tried to capture this effect in the model. In the future this 
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instead of the Km value. To capture the effect of YddG expression, we introduced a term 
“G”, which is dependent on the yddG expression and arabinose concentration and 














     [8] 
where CTrp and CTyr are the concentrations of Trp and Tyr in the medium in mM and 
[ind1] is the concentration of inducer 1 in mM. Kind1 is the dissociation constant for 
inducer 1 and its corresponding activator, and KW and KY are the “affinities” or Km 
values -- the concentrations (in mM) of Trp/Tyr when the growth rate of the W or Y 
strain is half of its maximal value. 
After incorporation of equations [7] and [8], the model now more accurately 
simulates the growth trends observed experimentally. As the inducers increase, the 
growth rate of the co-culture decreases due to the metabolic burden (Figure 2.13). The 
lowest points are at the highest inducer 2 concentrations (meant to mimic NaProp). The 
maximum growth rate is not at (0,0), but is along the [inducer 2] = 0 edge, as observed in 
the experiments (Figure 2.13A). The simulation results for the mid- and end-exponential 
ratio (Figure 2.13B&C) are very similar. They predict reduced ratios for higher [inducer 





Figure 2.13 Simulation results with the updated burden model. Growth rate (A), mid-exponential (B), and 
end-exponential (C) Y:W ratio for general inducers 1 and 2. Here the strains are labeled as Y and W since 
the equations are meant to mimic the Y3 and W3 interaction and effect of actual inducers, but do not use 
actual inducer and α values. 
Obviously this model still does not capture all of the interesting dynamics 
exhibited by the co-culture. In the Discussion, Section 2.5 we discuss options for refining 
the model, such as investigating potential changes in the cellular requirements (the β 
parameter) for Trp and Tyr of W3 and Y3, respectively. 
2.4.4 Programming the synthetic consortium with the Design Space 
To utilize the above results for programming the consortium, we reversed the 
relationships of growth rate/strain ratio versus inducer concentrations and defined a 
design space represented by two contour plots (see Methods 2.3.6 for details). For 
achieving a specific growth rate and end-exponential ratio combination, Figure 2.14A 
and Figure 2.14B show which arabinose and propionate concentrations should be used, 
respectively. Similarly, Figure 2.15 can be used to determine the inducer concentrations 
for achieving a specific growth rate and mid-exponential ratio combination. Due to the 
high nonlinearity of the dependence of growth rate and strain ratio on inducer 
concentrations (Figure 2.10), the design spaces are also very nonlinear and exhibit 
irregular shapes (Figure 2.14A&B, Figure 2.15A&B). For both arabinose and propionate, 
the two-dimensional contour plot has both “steep” areas featuring tight contour lines, 
where substantially varying the inducer concentration is required to change the 
growth/ratio, and almost “flat” regions, where small changes of inducer concentration 
correspond to large changes of growth/ratio. Additionally, higher concentrations of 






























































































higher propionate concentrations seem to produce lower growth (except the small region 
on the left, Figure 2.14B). 
 
Figure 2.14 Design space and testing for the end-exponential ratio. (A, B) By inverting the relationships of 
growth rate/strain ratio vs. inducer concentrations, a design space was generated to represent the two-
dimensional space of achievable growth rates and strain ratios, and to determine the arabinose (A) and 
propionate (B) concentrations for a desired growth rate and end-exponential ratio combination.  The 
colored circles are "prediction" points and the asterisks of the same color are the “actual” results of using 
that combination of arabinose and propionate in the co-culture. The colors denote inducer combinations: 
purple (0.11%, 8mM); pink (0.02%, 5mM); orange (0.13%, 30mM); red (0.06%, 12 mM); yellow (0.06%, 
20mM); black (0.11%, 5mM). (C, D) Comparing the predicted and actual outcome for growth rate (C) and 
end-exponential ratio (D) in bar graph form; the predictions are in darker colors and the actual 
(experimental) results are in lighter ones. Error bars: ± standard deviation. The mid-exponential ratio 
design space is shown in Figure 2.15. 
 
To test the accuracy of the design space, a “prediction” point was first selected at 
the same position in both plots of Figure 2.14A&B, which would correspond to a 
particular growth rate and ratio. For example, the yellow circles correspond to a growth 
rate of ~0.31 1/hr and an end-exponential ratio of ~5. At this specific point, using the 
contour lines, the inducer concentrations can be estimated to be 0.06% arabinose (Figure 
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this specific combination of inducers and the resulting growth rate and ratio (the “actual” 
data) were compared with the “predicted” values. Results from six such tests are 
illustrated in Figure 2.14 (panels A&B: circles – predictions, asterisks – actual values 
from experiments; panels C&D: bar graph comparisons). For the growth rate, two out of 
these six tests showed good agreement between predicted and actual outcome (within two 
standard deviations, Figure 2.14C: 8 mM, 0.11%; 30 mM, 0.13%); for the end-
exponential ratio, four of them are reasonably accurate (within two standard deviations, 
Figure 2.14D: 8 mM, 0.11%; 12 mM, 0.06%; 20 mM, 0.06%; 5 mM, 0.11%). These 
results confirm our expectation that the steeper regions of the design space are more 
accurate, while the flatter regions are more difficult to target.  It is also worth noting that 
the contours could explain, at least partially, the deviation of the actual outcome from the 
prediction. For example, for the inducer concentration of 0.06% arabinose and 12 mM 
propionate, the predicted and actual values of growth rate are significantly different 
(Figure 2.14A, red circle and asterisk), but the plot illustrates how the point may have 
moved around the arabinose surface along the 0.06% contour. 
 
Figure 2.15 Design space and testing for the mid-exponential ratio. (A, B) Graphs created as for the end-
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growth rate and mid-exponential ratio combination.  The colored circles are "prediction" points and the 
asterisks of the same color are the “actual” results of using that combination of arabinose and propionate in 
the co-culture. The colors denote inducer combinations: white (0.13%, 0mM); purple (0.08%, 12mM); blue 
(0.11%, 25 mM); black (0.10%, 5mM); yellow (0.11%, 20mM); pink (0.12%, 8mM). (C, D) Comparing the 
predicted and actual outcome for growth rate (C) and mid-exponential ratio (D) in bar graph form; the 
predictions are in darker colors and the actual (experimental) results are in lighter ones. Error bars: ± 
standard deviation. 
 
2.5 Discussion and conclusion 
As described above, we have constructed a proof-of-principle biological circuit to 
regulate the growth rate and composition of a two-member E. coli consortium based on 
tunable symbiosis. The resulting co-culture is able to achieve a continuous range of 
growth rate and composition; in addition, we show that the system can be “programmed” 
reasonably well for desired growth rate or strain ratio. The symbiotic scheme (two 
auxotrophic strains cross-feeding amino acids) has been proposed and examined in 
previous work, most notably with the yeast system by Shou et al. (21). Building on this 
basic concept in our work here, we have devised a novel approach for continuously 
tuning two important properties of synthetic consortia: the growth rate and community 
composition. Whereas previous work largely focused on using synthetic circuits to 
investigate the mechanism of microbial interactions such as mutualism, the main 
objective of this study has been developing a tool for engineering a synthetic microbial 
community, which can be deployed in various applications.  
The main issue of our current system is that the metabolic burden partially masks 
the cross-feeding benefits with regard to the growth rate. This obstacle could potentially 
be overcome by using plasmids of lower copy number, by modifying the promoters to 
achieve more appropriate expression levels, or by transferring the system to the 
chromosome. On the other hand, since the gene expression level would be lower, the 
effect of activating the circuit might also become smaller. Nevertheless, we expect that 
eliminating or reducing the metabolic burden would lead to larger and more predictable 
ranges of growth rate and strain ratio upon addition of inducers. This would also improve 
the quality of the design space, which ideally would exhibit monotonic relationships 
between inducer levels and desired growth/ratio (as would be expected for the design 
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space corresponding to our basic model) and hence provide better estimates of inducer 
concentrations for generating the desired co-culture property.  
In terms of our burden model, we had begun to capture some of the ratio 
dynamics but it could obviously be refined further. As illustrated in Figure 2.8, there is an 
interesting relationship between the inducer concentration and “affinity” parameter Km. 
While the change in Km did not appear to be as significant as we had hypothesized, 
especially for the Trp auxotroph, W3, there is a change in the Km value that is observed 
when the arabinose and sodium propionate is varied. For the W3 strain, as arabinose is 
increased the affinity actually increases (Km goes down) and then decreases (Km goes up) 
as arabinose is increased from 0% to 0.08% to 0.15%. Although we originally focused on 
tuning the α value and the max growth rate decrease, the genetic changes may be 
affecting the β parameter, which is reflected in what was termed the “Km”, just based on 
the format of the Hill equation. In this case the “affinity” of the cells for the essential 
metabolite is probably very representative of the β parameter, defined as the cell’s 
requirement for that specific amino acid. One way to test changes in this parameter would 
be to do a series of bioassays (as was done for Trp/Tyr -- see Methods, Section 2.3.4) 
combined with data from expanding the “affinity” experiments, Figure 2.8, to determine 
the lowest concentration of Trp/Tyr that would support growth for each auxotroph, with 
and without the tuning genes, and with varying amounts of inducer. Then an empirical 
expression could be derived for the relationship between inducer concentration and the β 
parameter, as was done for the metabolic burden. This could then be incorporated into the 
model to make the β tunable and dependent on inducer concentration, as well as the α 
value. 
We also want to point out that our measurement of consortium composition (i.e. 
strain ratio), via a combination of absorbance and fluorescence readout, is not ideal and 
occasionally showed large variation among replicates when the ratio deviates 
substantially from one and changes rapidly over time. In addition to inherent variability 
of the biological system (e.g. due to gene expression), another possible source could be 
the population variances in YFP expression and maturation. In our current system, GFP 
variant eYFP is constitutively expressed on the chromosome in the tyrosine auxotroph 
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but its expression is not very high. Furthermore, YFP in its native state has a slow 
maturation time (45), which may be causing the inaccuracy and large variation. Using 
another fluorescent protein with higher signal/noise ratio and faster maturation time could 
potentially reduce or eliminate these issues and hence improve the measurement. It will 
also be worth exploring in the future alternative methods, such as qPCR and 
fluorescence-activated cell sorting (FACS), to achieve better accuracy.  
Finally, we would like to emphasize that the approach reported in this work for 
regulating and programming a two-member synthetic microbial consortium and its 
extensions could be readily transferred to more complex systems consisting of different 
microbial strains or species. Two key components are required to construct such a 
regulatory circuit. First, the two consortium members need to form an inter-dependent 
relationship. Part of this inter-dependence might already exist when a synthetic microbial 
consortium is assembled (46, 47). If a complete cross-feeding loop is not in place, genetic 
manipulation such as the gene deletions we conducted in this work to generate 
auxotrophs will be needed. Second, genes that can affect the export of cross-fed 
metabolites need to be regulated, which can be achieved by various means, for instance 
through the usage of chemically inducible promoters as illustrated in this work. The 
resulting tunable microbial consortia can potentially be utilized for many applications. 
For example, complete and efficient co-fermentation of hexose and pentose sugars is one 
of the major obstacles in effectively converting lignocellulosic biomass into fuels (48). 
Existing strategies to optimize the sugar utilization using a bacterial co-culture include 
delaying the inoculation time of one of the strains or changing the inoculation ratio (49). 
Tuning the composition of the co-culture during growth might be easier and more 








Chapter 3  Engineering a two-member E. coli consortium for 
conversion of five- and six-carbon sugars to isobutanol 
3.1 Summary 
As described above, consolidated bioprocessing (CBP) of lignocellulosic biomass 
is a promising method for overcoming current and future liquid fuel shortages.  Some of 
the challenges that remain in CBP are complete utilization of five carbon sugars such as 
xylose, as well as achieving high titers of next-generation biofuels on actual biomass 
rather than on defined laboratory media. To address this issue we have constructed a 
biculture of two E. coli specialists converting five- and six- carbon sugars into isobutanol 
that consumes both types of sugar and can achieve relatively high titers and yields of 
isobutanol on defined laboratory media and on AFEX-pretreated corn stover hydrolysate. 
We have also engineered the C5 specialist to consume xyloligosaccharides by 
introducing a xylodextrin transporter and xylosidase, xynTB, from Klebsiella oxytoca. 
These genes were assembled onto the isobutanol production plasmid, pSA55, for 
simultaneous xylodextrin utilization and isobutanol production. We demonstrate the 
consumption of xylodextrins on minimal media and the growth of the xynTB-containing 
strain on the corn stover hydrolysate.  
The materials presented in this chapter are currently in preparation: Kerner A*, 
Minty J*, Kistler S, Singer M, Faulkner I, Balan V, and X. N. Lin. A synthetic 
Escherichia coli consortium for efficient conversion of hexose and pentose monomers 




The current energy crisis and environmental sustainability of our liquid fuel 
reserves remains a global obstacle with no clear and immediate solution. Particularly in 
the United States, the dependence on foreign oil has become an environmental, political, 
and ethical dilemma. Biofuels can be a potential solution to this problem, but corn- and 
starch-derived fuels are not sufficient on their own; even if all the corn produced in the 
U.S. were used instead for fuel production it would only make up about 15% of our 
country’s fuel needs (50). Cellulosic biofuels, which are biofuels derived from 
lignocellulosic biomass such as grasses, woods and crop residues, could potentially 
displace our petroleum dependency. There are many advantages to using cellulosic 
biomass as a feedstock, including renewability, abundance, wide geographic distribution, 
and low greenhouse gas emissions (51). Additionally, these feedstocks avoid competing 
with the food supply, unlike corn- and starch- based feedstocks (50); current estimates for 
U. S. production are 1.4 billion tons of cellulosic biomass annually (52).  
Production of biofuels from cellulosics is a three-step process (51). First, plants 
store solar energy in the form of cellulose and hemicellulose; next, these compounds are 
separated from lignin and other macromolecules and broken down by physical or 
chemical pre-treatment and enzymatic saccharification.  Finally, the five- and six-carbon 
sugars that are produced during saccharification are fermented into biofuels. Although the 
general process seems straightforward, it is still a long way from being optimized for 
large-scale production.  
Cellulosic biomass is made up of three main components: cellulose, hemicellulose, 
and lignin, but the ratio of these three components varies between plants and between 
parts of the plant (53). To solve this problem, researchers have already begun to use 
novel genomic techniques to identify organisms and genes that could be useful in 
standardizing the feed composition (51). Additional issues include the high cost of 
removing the lignin by pre-treatment and the high cost of cellulase and hemicellulase 
production (enzymes used to degrade cellulose during saccharification) (50). Efforts to 
decrease the costs of pretreatment are discussed in the next section. In order to overcome 
the second issue, the cost of enzyme production, one could look to mimic natural 
 43 
microbial consortia such as those found in the cow rumen (54), which are naturally able 
to break down grasses and recalcitrant plants and produce such enzyme in situ. These 
consortia could then be used as the enzyme producer and/or production strain in the 
previously discussed system, consolidated bioprocessing (CBP). 
3.2.1 Pretreatment methods and next-generation biofuels 
Pre-treatment of lignocellulosic biomass is necessary to allow enzymes such as 
cellulases and xylanases access to substrates, which are often physically blocked by the 
presence of lignin and the tight packing of cellulose microfibrils. Cellulose makes up the 
largest component of the cell wall, at 35-50% of the plant dry weight, and is arranged in 
bundles of microfibrils surrounded by hemicellulose (20-40%) (50). Additionally, lignin 
(10-25% plant dry weight) is also present to give the cell wall rigidity and also protect 
against invading species. Thermochemical pretreament is needed to remove and/or 
rearrange the lignin and macromolecular structure to make fibers available for hydrolysis 
– this can increase the rate of hydrolysis from 3-10X depending on the method used (55). 
However, pretreatment can be quite expensive, contributing as much as 16-19% to a 
biorefinery’s total capital investment (55).  
Recently, more economical means of pretreatment have been developed, such as 
Ammonia Fiber Expansion (AFEX) (56, 57), a low temperature, dry-to-dry process 
where annhydrous ammonia is added to the prewetted biomass. This process retains the 
macromolecular structure of the cellulose and hemicellulose, but reduces the degree of 
polymerization to increase substrate availability (57). The polymers then still need to be 
enzymatically hydrolyzed, but less inhibitors are produced than in other methods so the 
feedstock can be used directly in fermentation experiments without further detoxification 
(58). Improved ammonia recovery methods have also reduced cost estimates -- in 
simulations by Sendich et al. that took into account these improvements and by using the 
minimum amount of water and ammonia possible, the minimum ethanol selling price 
(MESP) was predicted to decrease from the previous estimate of $1.41 per gallon to 
about $1.03 per gallon if simultaneous saccharification and fermentation is used for corn 
stover conversion (Figure 3.1) (56). For a CBP process, however, this is decreased even 
further to about $0.80 per gallon (56). 
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Figure 3.1 Comparison of the predicted MESP for various process simulations on corn stover, adapted from 
(56). Old data from a 2004 NREL study are compared with updated AFEX parameters and various 
configurations. Red arrow indicates the MESP of AFEX with the new parameters incorporated, for a CBP 
approach. Abbreviations not previously explained: new NH3 recovery (NEW), NH3 recompression 
(COMP), old AFEX parameters (OLD); updated AFEX parameters (UPD).  
In our case, AFEX has been demonstrated as an efficient pretreatment method for 
our chosen feedstock, corn stover, which is pretreated and enzymatically hydrolyzed by 
the Biomass Conversion Research Laboratory (BCRL) at Michigan State University 
using a commercial enzyme mixture (see Methods for AFEX conditions and further 
details). This process results in glucose and xylose titers up to ~58 and ~29 g/L, 
respectively, though this may vary slightly from batch to batch (Venkatesh Balan, BCRL, 
personal communication). 
In order to reach recent energy goals and reduce the impact of petroleum use, it 
will be necessary to find other sources of liquid fuel substitutes other than corn- and 
sugarcane-derived ethanol or biodiesel. Several issues with 1st-generation ethanol 
include: competition with land used for food crops, contribution to increasing food and 
energy prices, and high cost of production which necessitates the use of subsidies to be 
competitive (59). Vegetable oil-derived biodiesel, used widely in Europe, only contains 
91% of the energy of D2 diesel and suffers from distribution issues in cold climates, 
where low temperatures may cause waxes to form in the fuel (60). A solution to these 
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problems may be 2nd-generation biofuels, which are derived from lignocellulosic sources 
such as forest residues, grasses, and sugarcane bagasse. Depending on the type of 
biomass, higher energy yields may be obtained than from 1st-generation feedstocks, and 
when wastes from other processes are utilized they will then also not compete with food 
crop production (59). However, we are currently much less experienced at producing 
fuels from these feedstocks, so it will likely be some time before the switch can be made 
from corn or sugarcane ethanol to fuels produced from lignocellulosic sources. 
There are many feedstock and fuel alternatives to corn-derived ethanol (Table 3.1) 
the difficult part will be finding or designing either a synthetic or natural microbe capable 
of producing industrially-relevant yields (60). One promising fuel alternative to ethanol is 
butanol, which has a higher energy content than ethanol (84% vs. 65% of the energy 
contained in gasoline) and, unlike ethanol, is less hygroscopic and can therefore more 
easily become part of our current fuel infrastructure (5). Isobutanol and 1-butanol have 
also been produced in E. coli in relatively high titers (61-63), making these fuels a good 
starting point for further process optimization. We have chosen to focus on the 
production of isobutanol in particular. 
Table 3.1 Properties of 2nd-generation fuel alternatives. Adapted from (60). 
Fuel	  
type	  
Major	  components	   Properties	   Potential	  advanced	  
biofuels	  
Gasoline	   C4-­‐C12	  hydrocarbons;	  
Linear,	  branched,	  cyclic	  
aromatics	  
Octane	  number	  (87-­‐
91);	  Energy	  content	  
Butanol,	  isobutanol,	  short-­‐
chain	  alcohols,	  short	  
branched-­‐chain	  alkanes	  
Diesel	   C9-­‐C23	  hydrocarbons;	  
Linear,	  branched,	  cyclic	  
aromatics	  
Cetane	  number	  (40-­‐
60);	  Good	  cold	  
properties	  
Fatty	  alcohols,	  alkanes,	  
linear	  or	  cyclic	  isoprenoids	  
 
3.2.2 Isobutanol production in E. coli 
E. coli is not a natural producer of 1-butanol or isobutanol, however Atsumi et al. 
were able to engineer isobutanol production by co-opting the L-valine biosynthesis 
pathway and expressing a heterologous 2-keto acid decarboxylase and alcohol 
dehydrogenase (Figure 3.2) (61). The L-valine biosynthesis pathway produces 2-
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ketoisovalerate from pyruvate, which is then converted into L-valine (64). The final steps 
in the Erlich pathway (65) can then be used to convert the 2-keto acid into an alcohol 
using a 2-keto acid decarboxylase (KDC) and alcohol dehydrogenase (ADH) (Figure 
3.2). In this case, the KDC used was Kivd from Lactococcus lactis and the ADH was 
Adh2 from Saccharomyces cerevisiae – both were placed under the control of an 
inducible promoter, PLlacO1. To further increase isobutanol production, several genes 
from the L-valine pathway were also overexpressed on a plasmid, ilvIHCD, under control 
of the same promoter. However, the ilvIH genes (encoding the isoenzyme acetohydroxy 
acid synthase) were then replaced by the alsS gene of Bacillus subtilis, which has a 
higher affinity for pyruvate (61) and would then direct product formation towards L-
valine/isobutanol rather than towards other products such as L-isoleucine. Six 
chromosomal genes were also knocked out to decrease byproduct formation and 
competition for pyruvate: adhE (ethanol), ldhA (lactate), frdAB (succinate), pta (acetate), 
fnr, and pflB. The final rationally-designed strain JCL260 was able to produce up to ~300 
mM isobutanol (22 g/L, 86% theoretical yield) after 120 hours with one round of 
glucose-feeding (61). 
 
Figure 3.2 Isobutanol production in E. coli using the valine biosynthesis pathway, adapted from (61). (A) 
Converting 2-ketoisovalerate into isobutanol via the Erlich pathway. (B) Conversion of glucose to 
isobutanol, overall schematic. 
Isobutanol production was also achieved by the same group using evolution as 
opposed to rational design (63). The precursor strain to the above-mentioned JCL260 
(JCL16), which does not contain the chromosomal mutations, was evolved for increased 
B A 
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isobutanol production by selection on a L-valine analog, norvaline, which in high 
concentrations is normally toxic (63). If a strain could grow well in media containing this 
analog, then it is likely that it contains mutations favorable for norvaline and valine 
secretion from the cell. Since the valine and isobutanol pathways are intertwined when 
the KDC and ADH genes are introduced, then increased valine secretion should also lead 
to increased isobutanol secretion. To test this, the JCL16 strain was mutagenized using 
N’-nitro-N-nitrosoguanidine (NTG) and then evolved on liquid media containing 
norvaline. Resistant mutants were selected on plates containing norvaline, screened for 
increased isobutanol production, and then the process was repeated. After transforming 
with the relevant plasmids, the resultant NV3 strain was found to produce up to 13.6 g/L 
isobutanol compared to JCL260 which produced 21.0 g/L isobutanol (63). After 
“repairing” a key mutation in rpoS, the titer could be increased to 21.2 g/L isobutanol 
(strain NV3r1). A full list of the mutations in strain NV3 is shown below in Appendix 
Table 1.  
In our own hands, the NV3 strain produced more isobutanol than NV3r1 with 
plasmids pSA55 and pSA69 and only one round of glucose feeding, so we chose this as 
our base strain for the two-member consortium. It should also be noted that we used the 
plasmids pSA55 and pSA69 for isobutanol production, whereas in the evolution study, 
plasmid pSA69 was combined with plasmid pSA65 (66), which encodes a different 
alcohol dehydrogenase gene from L. lactis, adhA. This newer plasmid, pSA65, showed 
better performance than the pSA55 plasmid, so this might be one of the reasons the 
strains performed differently in our hands. This is discussed further in the Discussion and 
conclusion, Section 3.5 
The highest titer so far reported for isobutanol is 50.8 ± 1.1 g/L by the JCL260 
pSA65/pSA69 strain, which was achieved under aerobic conditions in a 1L bioreactor in 
72 hours on 55 g/L glucose with intermittent glucose feeding cycles (67). Interestingly, 
the JCL260 strain outperformed the evolved isobutanol-tolerant strain SA481 (68) which 
produced only 23 ± 4.4 g/L isobutanol under the same conditions. A gas-stripping 
mechanism was used to remove the isobutanol from the fermentation broth, which can be 
toxic at titers over 8 g/L. Two condensers were attached to the bioreactor, and then 
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oxygen was sparged in to help remove the isobutanol, which was condensed into water in 
receiver B and D (Figure 3.3). This product removal strategy allowed the production of 
much higher levels of isobutanol than had been previously reported in shake flasks (22 
g/L, (62)). These results suggest that the gas stripping process was an effective removal 
strategy and that such a process will be necessary in order to reach industrially relevant 
levels of isobutanol production. Additionally, these production strains perform much 
differently depending on whether or not the toxic product is removed, so care should be 
taken when scaling up such bench-scale processes since the results are likely to be much 
different. 
 
Figure 3.3 Diagram of fermentation and removal of isobutanol via gas stripping, adapted from (67). 
 
3.2.3 Consortia vs. “Superbug” for fuel production and sugar co-utilization 
It remains to be seen whether a microbial consortia or a “superbug” will be the 
best option for biofuel production, but both strategies have been thoroughly investigated. 
Recent work suggests that a co-culture may be more efficient than a monoculture with 
regard to alternative fuel production in general. When a cellulolytic, hydrogen-producing 
bacterium, Clostridium thermocellum, was cultured with a non-cellulolytic hydrogen 
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producer, Clostridium thermopalmarium, the overall titer of H2 on filter paper from a 
1:0.05 co-culture was much higher (~400 ml/L) than that produced by the C. 
thermocellum alone (176 ml/L), even though this strain can produce hydrogen from 
cellulose on its own (69). The increased benefit may result from the reduced ethanol and 
acetate production; the concentration of both of these byproducts decreased when the 
strains were cultured together (69). 
One of the remaining challenges for CBP systems is complete utilization of five-
carbon sugars (e.g. xylose or arabinose) when six-carbon sugars (e.g. glucose) are also 
present, since the six carbon sugars will naturally be utilized first and may also inhibit 
utilization of the five carbon sugars (48, 70). In sequential utilization, by the time the 
glucose is used up, the product titers (such as ethanol) have already reached levels that 
may reduce xylose utilization to extremely slow rates, further complicating the problem 
(70). There are various examples of attempts to engineer one strain to co-utilize six- and 
five-carbon sugars, as well as examples of consortia designed for the same purpose. Co-
utilization of cellobiose (a glucose disaccharide) and xylose was completed in an 
engineered E. coli strain adapted for growth on cellobiose (71). Although rates of xylose 
utilization reached ~0.13 g/L/hr, it was not clear how this strain would perform with 
glucose present as well. Similarly, a Saccharomyces cerevsiae strain was also engineered 
to co-utilize cellobiose and xylose, achieving higher yields of ethanol on the sugar 
mixture as opposed to each sugar alone in the same time frame (0.39 g/g vs. 0.31-0.33 
g/g) (70). This result indicates that co-utilization, as opposed to sequential utilization, 
might be more effective with regard to isobutanol production in E. coli as well. Although 
the researchers did test this strain on a “simulated” hydrolysate containing glucose, 
xylose and cellobiose, it is not clear that it would be able to perform as well on an actual 
hydrolysate. It would be interesting to see how a co-culture would perform compared to 
this strain in the same conditions. 
In contrast, co-utilization of sugars by a microbial consortium has also been 
demonstrated extensively (6, 72, 73), although so far there have been no studies, to our 
knowledge, that also demonstrate this co-utilization on an actual lignocellulosic biomass 
coupled to isobutanol production. As briefly described earlier, Eiteman et al. were able to 
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achieve simultaneous consumption of both glucose and xylose by engineering two E. coli 
strains to preferentially use either one sugar or the other (6). In an aerobic batch culture, 
the co-culture completely consumed each sugar in about 15% less time than the separate 
processes. Also, the co-culture demonstrated an ability to adapt to changing culture 
conditions, as the ratio of the specialists changed depending on the composition of the 
feed stream in a fed-batch process (6). This also demonstrates one of the advantages of a 
co-culture over a monoculture: the ability to adapt to a changing extracellular 
environment. 
In another interesting report by the same group, a four-member co-culture was 
designed to consume three sugars (glucose, xylose, and arabinose) and one waste product 
(acetate) by engineering specialists that would each utilize only one of these carbon 
sources (73). In a bioreactor containing 14 g/L glucose, 11 g/l xylose, 7 g/L arabinose, 
and 3 g/L acetate, all of the sugars and acetate were consumed within 10 hours (73). 
While these concentrations are low, this demonstrated the ability of a consortium to 
simultaneously consume three sugars, as well as remove a possibly detrimental waste 
product as may be produced in a lignocellulosic fermentation. 
Lastly, as described above in Section 1.2, the yeast consortium engineered by Tsai 
et al. to produce a synthetic cellulosome is an excellent example of a situation in which a 
modular consortium is vastly preferable to a monoculture or “superbug” (Figure 1.4) (8). 
Up to 93% of the theoretical yield of ethanol on cellulose was obtained with the 
optimized consortium, as compared to previous studies with one strain secreting all four 
components (62% of theoretical yield). With the consortium, the metabolic burden of 
expressing three different enzymes and one scaffold was spread across four separate 
engineered strains, and each could be manipulated individually. For example, the 
exoglucanse was switched out in one of the partners, in favor of an enzyme with better 
scaffold-docking properties. This would be much more difficult to achieve with one 
strain, where the genetic manipulations needed to swap out genes might affect the 
expression or sequence of the heterologous genes that have already been added. 
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3.2.4 C5 specialist construction and xylodextrin utilization 
Since E. coli is naturally a hexose specialist, it is necessary to knock out several 
genes in order to engineer preferential xylose utilization. It has been shown in several 
studies that knocking out the genes for glucose uptake and phosphorylation will render 
the cell unable to use glucose (6, 74). To achieve this, we first knocked out ptsG which 
encodes the glucose-specific transporter (enzyme IICBGlc) of the glucose 
phosphotransferase system (PTS) (75). The cell can still transport glucose via the 
mannose PTS (75), so manX, a subunit of the mannose permease (enzyme IIABMan) that 
participates in the phosphorylation of exogenous mannose, as well as glucose, was also 
knocked out. This protein complex is localized to the cytosolic side of the membrane. 
Previous work has shown that knocking out manZ is also an effective strategy (6). Lastly, 
the glucokinase gene, glk, should be removed in order to prevent utilization of 
intracellular glucose. Glucokinase uses one ATP molecule to phosphorylate β-D-glucose 
to β-D-glucose-6-phosphate. It is not necessary for growth on glucose but can be utilized 
when the PTS system can no longer transport and phosphorylate glucose or there are low 
extracellular concentrations of glucose (76). Removal of all three of these genes was 
necessary and sufficient for preferential xylose utilization in a glucose and xylose-
containing medium, as demonstrated in the Results, Section 3.4.1 below. Description of 
the process for removing these genes in discussed in the Methods, Section 3.3.1. 
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Figure 3.4 Phosphotransferase system (PTS) highlighting participation of the pstG and manX genes, 
adapted from (75).  General PTS proteins are shown on the left, wherease the substrate specific proteins, I, 
II, or III, are shown on the right, where some are membrane-associated and some are cytosolic. 
As discussed above, after enzymatic hydrolysis the CS hydrolysate still contains 
oligomers of glucose and xylose that have not been completely hydrolyzed to their 
monomeric forms (58). E. coli is not naturally able to utilize oligomers of either sugar, 
though it does contain two cryptic operons for utilization of cellobiose (chb and asc) (77). 
The xylodextrin utilization operon from Klebsiella oxytoca, xynTB, contains a 
xylodextrin transporter (xynT) and a xylosidase (xynB) (74)--a schematic is shown in 
Figure 3.5. When expressed in E. coli this operon allowed for utilization of xylodextrins 
up to a degree of polymerization of six (xylobiose to xylohexaose) (74). We obtained a 
plasmid containing these genes under control of the lactose-inducible promoter 
(pLOI3708) from this previous study, and then cloned the operon behind the ADH2 gene 
in plasmid pSA55 to couple the isobutanol production and xylodextrin utilization. A map 
of the completed plasmid is shown below (Figure 3.5) and a strain list is given in the 
Results section (Table 3.2). Details of the plasmid construction are given in the Methods, 





Figure 3.5 (A) Xylodextrin uptake and hydrolysis by the K. oxytoca xynTB genes. (B) xynTB insertion onto 
the pSA55 plasmid for isobutanol production and xylodextrin utilization 
 
3.3 Methods 
3.3.1 Strain construction 
Our base strain for the E. coli hexose specialist is NV3 (63), and was termed 
“NC6”. A full strain list is given in Table 3.2. The pentose specialist was constructed by 
knocking out genes for glucose transport and utilization: ptsG, glk, and manX (78), and 
was named “NC5”. Each gene was knocked out via P1 transduction (42) using lysate 
grown on the corresponding Keio collection strain (JW1087-2, JW2385-2, JW1806-1) 
obtained from the CGSC (43). After each transduction the kanR selection cassette was 
removed using the heat-sensitive FLP recombinase (42) and then the next gene was 
deleted. Each specialist was then transformed via electroporation with plasmids pSA55 
and pSA69 (61) and the results were confirmed via ethidium bromide (EtBr) gel 
electrophoresis (see Table 3.2). The plasmid pSA55 contains genes kivd and ADH2 under 
control of the PLlacO1 promoter, induced via the addition of IPTG. The plasmid pSA69 
contains genes alsS, ilvC, and ilvD also under control of the PLlacO1 promoter. To create 
the NC5 xylodextrin utilization strains, the NC5 strain was transformed via 
electroporation with either plasmid pLOI3708 (74) or pAK6 (see construction details 
below). The results were confirmed on an EtBr gel and by sequencing. 
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3.3.2 pAK6 (pSA55-xynTB) plasmid construction 
Plasmid pAK6 was constructed via the one-step isothermal assembly method, or 
the “Gibson Assembly” method (79). Primers were designed to amplify either the xynTB 
genes from plasmid pLOI3708 or the pSA55 backbone with 20 bp overhang flanking 
regions with a total overlap of 40 bp. Each template was amplified via PCR using the 
Phusion High-fidelity Master Mix from New England Biolabs (NEB), and then the 
fragments were assembled using the Gibson Assembly Master Mix (NEB). After the 1 
hour incubation at 60C, the reactions were diluted 3X and transformed via 
electroporation into NEB 10β electrocompetent cells (NEB). Transformants were 
screened by selection on ampicillin plates (100 µg/ml), miniprepping, and digestion with 
restriction enzymes to check for the correct length. Plasmids were analyzed on an EtBr 
gel and also confirmed via sequencing. The constructed vector was named “pAK6”. Once 
the plasmids were confirmed, the NC5 strain was then transformed with the constructed 
pAK6 vector. 
3.3.3 Microplate and flask cultivations using M9IPGX+YE media 
For the microplate and flask cultivations, mono- and co-cultures were cultivated 
in minimal M9IP medium (1X M9 salts, 0.01 mM FeSO4, 0.1 mg/L Thiamine HCl, 0.13 
mM CaCl2, 1 mM MgSO4, 0.2 ml/L MOPS micronutrients) with either 18, 36, or 48 g/L 
glucose or 18, 36, or 12 g/L xylose as indicated and 5 g/L yeast extract (YE, final 
medium termed M9IPGX+YE). IPTG was added to a final concentration of 0.1 mM for 
induction of gene expression. Ampicillin and kanamycin were added to final 
concentrations of 100 and 30 µg/ml, respectively. Frozen stocks were inoculated into rich 
LB medium with antibiotics and grown overnight to saturation, then washed twice with 
minimal M9 medium without yeast extract. Cultures were then diluted by 1:100 and 
pipetted onto a 96-well microplate (Costar) to a volume of 200 µl per well, which was 
then covered with an adhesive Mylar film to prevent isobutanol evaporation. Unless 
otherwise stated, four replicates were conducted per microplate sample. Cultures were 
grown for 48 or 72 hours at 30oC on a VersaMax (Molecular Devices) plate reader with 
shaking, and OD600 measurements were taken every 15 minutes. For the microplate 
experiments with NC5 pLOI3708, no kanamycin was added and the IPTG concentration 
was raised to 0.1 M for induction of pLacZ. M9 medium without sugar was used as the 
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base medium, to which the various xylodextrins (Megazyme) were added to a 
concentration of 2 g/L. For the flask experiments, cultures were inoculated in the same 
manner, and then washed with M9IP+YE medium without sugar. They were then diluted 
to a total cell density of 1:100 and grown for 48 hours at 30oC with shaking at 225 rpm in 
250 ml screw-top shake flasks with a total medium volume of 50 ml M9IPGX+YE with 
the sugar and antibiotic concentrations as described. IPTG was again added at 0.1 mM at 
the beginning of the cultivation. 0.5 – 1 ml samples were taken throughout the 
fermentation for OD600 and HPLC measurements. The final biomass yield was 
determined from a 1 ml sample washed and dried overnight. 
3.3.4 Determination of isobutanol and sugar concentrations via HPLC 
Glucose, xylose, and isobutanol concentrations were determined via High-
performance liquid chromatography (HPLC).  1 ml aliquots were taken throughout 
cultivation and then frozen until all samples were ready for processing. The aliquots were 
centrifuged and then the supernatant was removed and filtered through 0.2 µM filters. 
Sample volumes of 5 µl were run on a Rezex ROA column (Phenomenex) with a mobile 
phase of 0.005 N H2SO4 at 0.5 ml/min. Standard calibration curves were made by 
diluting 40% glucose or xylose or 15 g/L isobutanol stock in diH2O and filter sterilizing 
through 0.2 µM filters. Xylodextrin standards were obtained from Megazyme and were 
resuspended to a final concentration of 30 g/L with diH2O, then diluted to make a 
standard calibration curve. For determination of xylodextrin concentrations, the diluted 
standards and samples were filtered through 0.2 µM filters and run on the Rezex RSO 
column with diH2O as the mobile phase, at 0.3 ml/min. 
3.3.5 Corn stover hydrolysate preparation 
The corn stover hydrolysate was pretreated by ammonia fiber expansion (AFEX) 
as described previously (57). The enzymatic hydrolysis was performed at 6% glucan 
loading for 3 days with 15 mg enzyme per gram glucan using a combination of Ctec2, 
Htec2 and Multifect Pectinase enzymes (Ratio: 66.67%+16.67%+16.67%) by the 
Biomass Conversion Research Laboratory (Michgan State University, Lansing, MI) and 
sterile filtered and stored at 4 oC. Before each microplate or 50 ml falcon tube 
experiment, an adequate amount of hydrolysate was neutralized by addition of 5 M 
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NaOH to a pH of 7 and then re-filtered. If the hydrolysate was diluted with diH2O, the 
water was added and then the pH was adjusted. Antibiotics and IPTG were added in the 
same concentrations as with the M9IP medium. 
3.3.6 Growth experiments with CS hydrolysate 
Frozen stocks were inoculated into rich LB medium with antibiotics and grown 
overnight to saturation, then washed twice with minimal M9 medium without yeast 
extract. Cultures were then diluted by 1:100 and pipetted to a volume of 200 µl per well 
onto a 96-well microplate (Costar) covered with an adhesive Mylar film. Three to four 
replicates were conducted per microplate sample. Cultures were grown for 60 - 72 hours 
at 30oC on a VersaMax (Molecular Devices) plate reader with shaking, and either OD600 
or OD650 measurements were taken every 15 minutes. For the 50 ml falcon tube 
cultivations, cultures were inoculated in the same manner, and then washed once with 
minimal M9 medium and then washed again and resuspended in neutralized hydrolysate. 
The cultures were diluted to a total cell density of 1:100 in 10 ml hydrolysate in 50 ml 
falcon tubes with the sugar and antibiotic concentrations as described. IPTG was again 
added at 0.1 mM at the beginning of the cultivation. Cultures were grown for 96 hours at 
30oC with shaking at 225 rpm. Samples were taken throughout the fermentation for 
OD650 and HPLC measurements (0.2 – 0.5 ml sample volume). 
 
3.4 Results 
3.4.1 Two bacterial strains engineered to co-convert hexose and pentose sugars to 
isobutanol 
A diagram of the proposed two-member consortium is shown in Figure 3.6, 
wherein two E. coli strains are co-utilizing pentose mono- and oligosaccharides and 
glucose mono-saccharides to isobutanol. Each specialist preferentially consumes xylose 
or glucose, as well as xylodextrins in the case of the C5 strain. The strains are first grown 
on defined minimal media, which contains only glucose or xylose sugars, and then on 
lignocellulosic biomass (corn stover). The corn stover is pretreated using AFEX 
(ammonia fiber expansion) and then enzymatically hydrolyzed using a commercial 
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enzyme mixture (see Methods 3.3.5). The hydrolysis reaction produces monomers and 
oligomers of glucose and xylose, the latter of which can be utilized by the C5 specialist 
strain (containing either pLOI3708 or pAK6, Table 3.2) in this work. In the future gluco-
oligosaccharide utilization will also be engineered into the C6 partner. 
 
Figure 3.6 Process for converting AFEX-pretreated corn stover into isobutanol using E. coli specialist 
strains. The enzyme mixture breaks down the AFEX-pretreated corn stover, producing an enzymatic 
hydrolysate. The E. coli specialists then convert the sugars into isobutanol. Although the enzymes can 
hydrolyze the corn stover into glucose and xylose mono- and oligosaccharides, the glucose 
oligosaccharides are currently not utilized by the consortium. 
 
To construct the two-member consortium we first selected a promising base 
strain, the E. coli NV3, a strain derived from evolution on a L-valine analog, norvaline 
(63). NV3 has been shown to produce high titers of isobutanol--comparable to other 
rationally designed strains (61) (see above descriptions of JCL260 and NV3 design and 
creation). Since E. coli is a natural hexose-utilizer, we did not further engineer this strain 
to be a C6 “specialist” as it will preferentially consume glucose without any further 
manipulation. The NV3 hexose specialist was termed “NC6”. A full strain list is given in 
Table 3.2. The pentose specialist was constructed by knocking out genes for glucose 
transport and utilization: ptsG, glk, and manX (78), and was named “NC5” (Methods 
3.3.1). We found that all three knockouts were necessary to eliminate growth on glucose 
(data not shown). Next we transformed each specialist with two plasmids that will allow 
for isobutanol production, pSA55 and pSA69 (61), (see Table 3.2). The plasmid pSA55 
contains genes from the Erlich pathway that convert 2-keto acids to alcohols via 
heterologous genes from L. lactis and S. cerevisiae under control of the PLlacO1 











genes from the valine pathway under control of the PLlacO1 promoter, with two native E. 
coli genes and one homologous gene from B. subtilis. 
Table 3.2 Strains and plasmids used in this chapter 
Strain/plasmid	   Genotype	   Reference	  
NC6	   NV3	  evolved	  strain,	  various	  point	  mutations,	  
see	  supplementary	  information	  
(63)	  
NC5	   NV3	  ptsG	  glk	  manX	   This	  work	  
pSA55	   ColE1	  ori;	  AmpR;	  PLlacO1-­‐kivd-­‐ADH2	   (61)	  
pSA69	   p15A	  ori;	  KanR;	  PLlacO1-­‐alsS-­‐ilvC-­‐ilvD	   (61)	  
pLOI3708	   pNEB193	  derivative;	  AmpR;	  pLacZ-­‐xynTB	   (74)	  
pAK6	   ColE1	  ori;	  AmpR;	  PLlacO1-­‐kivd-­‐ADH2-­‐xynTB	   This	  work	  
 
3.4.2 Co-culture performance on mixed-sugar defined media 
After constructing the specialists, we first investigated the growth, sugar 
consumption, and isobutanol production profile in defined minimal medium with glucose, 
xylose, or both sugars to confirm that the monocultures were indeed either pentose- or 
hexose-utilizing specialists and that they could make isobutanol. As seen in Figure 3.7 
and Table 3.3, the NC5 strain was able to preferentially utilize xylose (Figure 3.7 A&B), 
while the NC6 strain preferentially used glucose (Figure 3.7 A&B). The growth profile is 
shown in Figure 3.7A. After about two days of growth on the mixed sugar media (18 g/L 
each of glucose and xylose), each monoculture produced 2.77 ± 0.06 and 5.80 ± 2.36 g/L 
isobutanol for the NC5 or NC6 strain, respectively (Figure 3.7D, Table 3.3).  
When grown in co-culture at a ratio of 1:1 NC5:NC6, however, 6.57 ± 3.00 g/L 
isobutanol was produced (Figure 3.7D and Table 3.3), more than either monoculture even 
though the NC6 strain is still diauxic and has the ability to consume both glucose and 
xylose. However, with the high variability of the NC6 and NC5:NC6 co-culture taken 
into account, the titers were not significantly different (Figure 3.7C, Table 3.3). After 48 
hours the cultures did not appear to be producing appreciably more isobutanol, so we 
examined the yield and productivity parameters at this point. The yield of isobutanol on 
the total amount of sugar consumed for the NC5, NC6 and NC5+NC6 co-culture was 
0.201 ± 0.014, 0.339 ± 0.033, and 0.334 ± 0.007 g/g, respectively, and the productivities 
were 0.058 ± 0.001, 0.121 ± 0.049, and 0.137 ± 0.062 g/L/hr (Table 3.3). For the co-
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culture, this corresponds to 81.5% of the theoretical yield (0.41 g/g). Looking at these 
values, it seems as if the co-culture was not significantly better than either monoculture, 
however the isobutanol produced per cell was much larger in the 1:1 co-culture, 4.03 ± 
0.007 g/gDM vs. 0.201 ± 0.014 or 0.339 ± 0.033 g/gDM, suggesting that the cells in the 
co-culture may have been significantly more efficient at converting sugar to isobutanol 




































































































































































































































































































































































































































































































































Unexpectedly, the NC5 strain was the least variable in the mixed-sugar media 
(previous C5 specialist test strains had shown poor performance and high variability). It 
also consumed 13.64 ± 0.49	  g/L xylose over 48 hours, demonstrating that it is indeed an 
efficient C5 consumer (Figure 3.7C and Table 3.3). When grown in co-culture with the 
NC6 at a ratio of 1:1, more xylose was utilized than in the NC6 monoculture, illustrating 
that the use of a co-culture when co-utilization is the desired outcome is, in this case, the 
better option. Interestingly, increasing the ratio of the NC6 partner (NC5:NC6 = 1:5) did 
not increase the isobutanol titer over that of the 1:1 co-culture in the mixed sugar medium 
with 36 g/L total sugars (Figure 3.8D), even though NC6 produces more isobutanol then 
the NC5 as a monoculture. Also, increasing the NC5 fraction to 5:1 did not result in more 
xylose utilization (Figure 3.8C). 
 
Figure 3.8 Growth profile (A), sugar consumption (B, C), and isobutanol production (D) on 18 g/L each of 
glucose and xylose defined media for co-culture combinations 5:1, 1:1, and 1:5 NC5:NC6. 
 
Additionally the amount of total sugar seems to greatly affect the final isobutanol 
titers. In contrast to above, previous studies with increased amounts of total sugars (36 
g/L each, 72 g/L total) showed that the co-culture produced significantly higher titers 
than either monoculture, however only one biological replicate of the NC6 strain was 
tested in this experiment (see Figure 3.9 and Table 3.4). The experiment was then 
repeated with lower sugar (36 g/L total) since much of the sugar was not consumed, and 
the above result was obtained (Figure 3.7). Interestingly, in the experiment with 72 g/L 
total sugar, the NC6 strain produced the least isobutanol, but with 36 g/L total sugar the 
NC5 has much lower titers than either NC6 or the co-culture (Table 3.3, Table 3.4). 





























































































































Figure 3.9 Mono- and co-culture sugar consumption and isobutanol production on defined media 
containing both glucose and xylose (36 g/L each, 72 g/L total) 
Table 3.4 Sugar consumption and isobutanol production of the NC5, NC6, and co-culture after about 2 days 
(48 or 50 hr) on 36 g/L of each sugar (72 g/L total). 













NC5	   0.22±0.46	   21.01±1.44	   3.74±1.06	   0.175±0.041	   0.075±0.021	  
NC6	   12.72	   0.22	   2.56	   0.198	   0.051	  
NC5	  +	  NC6	   18.28±0.09	   4.33±0.01	   4.93±0.23	   0.218±0.011	   0.099±0.005	  
 
There was also some growth inhibition and inhibition of product formation 
observed when both sugars were present in the media, which may be part of the reason 
there are such variable dynamics depending on the total sugar content. The growth rates 
of the strains in monoculture on the microplate were reduced when grown with both 
sugars present (Figure 3.10) and the NC6 strain produced more isobutanol when grown in 
glucose alone (Figure 3.10 and Table 3.5, 6.64 ± 0.15 vs. 2.56 g/L for 36 g/L total 
glucose).  










































































Figure 3.10 (Left) Growth rate inhibition when two sugars are present in the media (M9IPGX) vs. when 
only one sugar is present (M9IPG or X). YE = yeast extract. (Right) Glucose consumption and isobutanol 
production of the NC6 strain in 36 g/L glucose media. 
 





iButOH	  yield	  P/S	  	  
[g/g	  total	  sugar] 
iButOH	  productivity	  
qP	  [g/L/hr] 
NC6 20.19	  ±	  0.32 6.64	  ±	  0.15 0.329	  ±	  0.002 0.138	  ±	  0.003 
 
Part of the observed variability may have been due to the plasmid loss over the 
course of the culture growth. On the defined media we often observed that the pSA69 
plasmid (KanR, counts on LB Kan plates) was often lost to large degree by 48 hours, and 
the pSA55 plasmid (AmpR, counts on LB Amp plates) was either lost to a lesser extent 
or occasionally the colony count was even higher than for the LB plates without 
antibiotic (Figure 3.11). Since we only added antibiotics and inducer to the culture at the 
beginning of growth, this problem could be overcome by addition of antibiotics at a later 
time point, or by moving the plasmid genes onto the chromosome, an idea which will be 
discussed further in the Discussion, Section 3.5. 
While the titers of the NC6 strain on glucose alone are slightly higher, the results 
still demonstrate that a co-culture of specialists can outperform a monoculture even when 
compared to a diauxic strain such as the NC6 on a mixed-sugar defined media, which 
better approximates an actual biomass feedstock than a single-sugar media.  
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Figure 3.11 Example of plasmid loss at the end of the cultivation. Cell density was determined via plate 
counting. Two LB plates and one plate for each antibiotic, either LB ampicillin 100 µg/ml or LB 
kanamycin 30 µg/ml, were counted. The pSA55 plasmid confers resistance to ampicillin (AmpR), and the 
pSA69 plasmid to kanamycin (KanR). 
 
3.4.3 Sugar variation in defined media 
Before testing the co-culture on a lignocellulosic substrate, we wanted to 
determine if the optimal ratio for isobutanol production differed depending on the media 
composition, and if so, if there is an optimal ratio that might work well on the 
hydrolysate. We chose to look at two media compositions: 1:1 and 1:2 xylose to glucose 
(X:G), to mimic the approximate sugar concentrations of our chosen feedstock. We also 
investigated various ratios of specialist strains, from 5:1 to 1:5 NC5:NC6, on each media. 
The 5:1 culture was not included on the 1:2 media since it was not likely that this would 
be better for production. The total amount of sugars in these experiments was kept 
constant at 72 g/L, which is closer to the approximate hydrolysate composition. For the 
1:1 X:G media, that is 36 g/L of each sugar, and for the 1:2 X:G that is 48 g/L glucose 
and 24 g/L xylose. 
Overall there was not a vast difference among the co-culture mixtures on the 1:1 
media with 72 g/L total sugar (Figure 3.12A-C). Not much sugar was utilized in these co-
cultures, though the 5:1 co-culture consumed almost as much xylose as glucose, 
illustrating that if utilization of the different substrates is a main concern then modifying 
the partner ratio is a way to achieve that goal; oddly, the isobutanol titers were not as high 
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as in the experiments above (Figure 3.12C, Table 3.6). These experiments were not 
performed in duplicate due to the large number of flasks run simultaneously, so that may 
explain why the results are so different in this case. However they do give some insight 
into the co-culture dynamics—interestingly, although the 1:5 co-culture had the highest 
isobutanol yield at at 0.226 g/g, the 2:1 culture achieved the highest isobutanol titer and 
titer per cell at 3.98 g/L and 1.97 g/gDM (Table 3.6). It was surprising that the 2:1 
NC5:NC6 co-culture did better than the others on 1:1 media in several categories, as the 
NC5 often did not perform as well as the NC6 in monoculture. This illustrates the fact 
that the co-culture dynamics are often difficult to predict, but it would be best to repeat 
these experiments with more biological replicates, seeing how the variation from the 
other experiments affects the outcome. 
On the 1:2 xylose:glucose (X:G) media, the results were much different (Figure 
3.12D-F). The 1:2 co-culture was now producing the most isobutanol at 5.58 g/L (Figure 
3.12F, Table 3.7). This is not too surprising, since the co-culture ratio matches the sugar 
ratio in the medium. This culture also had the highest isobutanol yield (0.257 g/g total 
sugar) and highest titer per cell (3.03 g/gDM) (Table 3.7). Clearly, the optimal ratio for 
the 1:2 X:G sugar combination was also 1:2 NC5:NC6, which informed our choices for 











































































































































































































































































































































































































































































































































2:1	   13.97	   4.32	   4.49	   0.245	   2.02	   0.093	  
1:1	   12.12	   2.57	   3.35	   0.228	   2.07	   0.070	  
1:2	   19.24	   2.52	   5.58	   0.257	   3.03	   0.116	  
1:5	   14.76	   1.19	   3.81	   0.239	   1.70	   0.079	  
 
3.4.4 Isobutanol production on AFEX-pretreated corn stover hydrolysate 
Next we investigated the growth of the pair on an actual lignocellulosic feedstock. 
Our chosen feedstock is corn stover (CS) that has been pretreated using ammonia fiber 
expansion (AFEX) which was then enzymatically hydrolyzed to monomeric and 
oligomeric sugars using a commercial enzyme mixture (BCRL, MSU). A description of 
the enzymes used is given in the Methods, Section 3.3.5. The measured sugar 
concentrations for glucose and xylose in this batch of hydrolysate were ~55 g/L glucose 
and ~34 g/L xylose. The strains were first grown on the undiluted CS hydrolysate 
(titrated to a neutral pH of ~7) in microplate studies to ensure that these strains would 
indeed grow on the unsupplemented hydrolysate, which may contain some inhibitory 
compounds especially with regard to xylose utilization (58). The strains grew surprisingly 
well, achieving comparable growth rates compared to the control strain, wildtype K12 
MG1655, of up to 0.29 ± 0.19 1/hr for the NC5+NC6 co-culture vs. 0.37 ± 0.03 1/hr for 
the control, and maximum OD600 values up to 0.47 ± 0.10 vs. 0.37 ± 0.06 for the control 
(Figure 3.13) although the lag phases were longer and the growth more variable, as 
evidenced by the large error bars.  
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Figure 3.13 Growth rate (A), maximum OD600 (B) and growth profile (C) of mono- and co-cultures in 
undiluted hydrolysate on the microplate. Error bars are ± standard deviation of four replicates for (A, B) 
and + standard deviation only for (C). 
We next grew the strains on the undiluted CS hydrolysate in 50 ml falcon tubes to 
investigate the sugar consumption and isobutanol production, if any, on this complex 
feedstock. The hydrolysate was not supplemented with any nutrients, salts, or extra 
sugars beyond that which was produced via enzymatic hydrolysis. Each strain was grown 
in monoculture (two biological replicates) and in co-culture at ratios 2:1, 1:1, and 1:2 
NC5:NC6 (one biological replicate each). Although we saw variable growth on the 
microplate with some samples, we only tested one biological replicate for each co-culture 
since we were limited by the total amount of hydrolysate available. Again the strains 
grew quite well on the CS hydrolysate, with growth rates up to 0.242 1/hr for the 1:1 co-
culture (data not shown), which grew faster than either monoculture. In terms of sugar 
consumption, oddly not much sugar was utilized in any of the cultures, but we were able 
to obtain up to 2.29 g/L isobutanol with the 1:2 co-culture, which produced much more 
isobutanol than either of the other co-cultures and the mono-cultures (data not shown). 
The lignocellulosic biomass and the CS hydrolysate in particular have compounds 
that have may be inhibitory towards cells, especially with regard to xylose utilization 
(58), so we tried diluting the hydrolysate to 75% with sterile deionized water. Since the 
strains were barely utilizing all of the sugars present in the unmodified hydrolysate, we 
reasoned that the hydrolysate could be further diluted without a decrease in substrate 
availability and that the dilution might even increase isobutanol production and sugar 
utilization rates. Figure 3.15 shows the results on the 75% diluted CS hydrolysate after 4 
days (96 hours) of growth in 50 ml falcon tubes. The growth rates were higher when 
diluted with water and the growth patterns changed -- now the NC5 strain was growing 
A B C 
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slightly faster than the rest at 0.294 ± 0.002 1/hr followed by the 2:1 co-culture (Figure 
3.15A). The lag phases were also shortened by about 6 hours (Figure 3.15A) and were 
much shorter than the lag phases in the microplate experiment with undiluted hydrolysate 
(Figure 3.13C). The strains were also fairly stable in the diluted hydrolysate, as the error 
bars are quite small. In terms of sugar consumption, again not much glucose nor xylose 
was consumed; the 1:1 culture consumed the most glucose at 9.89 ± 0.37 g/L and NC5 
the most xylose at 3.98 ± 0.62 g/L (Figure 3.15B&C). The co-cultures outperformed the 
monocultures with regard to isobutanol production, with the 1:1 co-culture producing the 
highest titer at 2.95 ± 0.05 g/L isobutanol, though all of the co-cultures achieved titers 
above 2.8 g/L (Figure 3.15D, Table 3.8). With regard to isobutanol yield the NC6 strain 
performed similarly to the co-cultures, although the 1:2 co-culture was again the most 
efficient at isobutanol production, producing 0.267 g/g total sugar on both glucose and 
xylose, corresponding to ~65% theoretical yield (Table 3.8). 
The NC5 strain was again performing better than expected, as the growth rates 
and titer were higher than the parental NC6 (NV3) strain without modification. We also 
examined the ratios at the end of the growth (96 hours) using differential plate counting 
and found that the ratios changed to favor the NC5 strain (Figure 3.14). The ending ratios 
for the 2:1, 1:1, and 1:2 co-cultures were 4.59 ± 0.55, 1.98 ± 0.38, and 1.41 ± 0.41 
NC5:NC6. This may be due to some synergy between some of the NV3 base strain 
mutations (Appendix Table 1) and the genes knocked out to create the NC5. 
 
Figure 3.14 NC5:NC6 ratios at the end of cultivation on the diluted 75% hydrolsyate (“actual” ratio) 
determined via differential plate counting. X-axis labels denote the inoculation (“initial”) ratio. 





































































































































































































































































































































































































































































































3.4.5 Xylodextrin utilization by NC5 pLOI3708 
It had been previously found that the CS hydrolysate contains up to 9.89 g/L 
xylose oligosaccharides and up to 2.75 g/L glucose oligosaccharides resulting from 
incomplete enzymatic hydrolysis (Venakatesh Balan, personal communication, BCRL, 
MSU). In order to utilize this significant portion of oligomers left in the feedstock, we 
engineered the NC5 strain to utilize xylodextrins by introducing genes for xylodextrin 
transport and metabolism from Klebsiella oxytoca, xynTB (74),  as discussed above in the 
Introduction, Section 3.2.4. These genes were amplified from plasmid pLOI3708 (74) 
and then assembled to pSA55 behind the ADH2 gene under control of the pLlacO1 
promoter, creating vector pAK6 (see Table 3.2). We then transformed the NC5 strain 
with the completed pAK6 and pSA69 to allow for simultaneous xylodextrin utilization 
and isobutanol production (Methods). Plasmid pLOI3708 was also transformed into NC5 
as a control and test strain. 
To test the functionality of the xynTB operon, we first grew the NC5 xynTB-
containing test strain NC5 pLOI3708 in minimal M9 medium with only xylodextrins or 
xylose as a carbon source. With 2 g/L of each xylodextrin present (xylobiose – 
xylohexaose, X2 – X6) the cells were able to grow as well or better than the positive 
control, M9 + 5 g/L xylose (Figure 3.16). Although the maximum optical density values 
are low (the plate was accidentally left without shaking for the first ~21 hours, so there 
was less aeration) it can still be concluded that there is a definite difference between the 
growth on xylodextrins and the growth on the M9 medium without additional sugar 




Figure 3.16 Growth profile of the NC5 pLOI2708 strain on 2 g/L xylobiose (X2), xylotrioise (X3), 
xylotetraose (X4), xylopentaose (X5), and xylohexaose (X6). For comparison growth is shown on 5 g/L 
xylose, (+) control, and on M9 with no sugar (-) control. Positive error bars show the standard deviation of 
three replicates. 
 
Next we grew the NC5 xynTB-containing strain NC5 pLOI3708 on the hydrolysate 
and examined the changes in xylodextrin concentration vs. the NC5 strain without xynTB 
as measured by HPLC. As shown in Figure 3.17A, the growth of the NC5 pLOI3708 
strain was comparable to the NC5 strain without any plasmids, in contrast to the 
isobutanol–producing strains which grow more slowly. Very little glucose or xylose was 
utilized by these cultures, and the profiles were similar between the two strains (data not 
shown). However there is a clear difference in the consumption profiles of several HPLC 
peaks (Figure 3.17B,C,D), which we have preliminarily identified via HPLC as xylobiose 
(X2), xylotriose (X3), and xyloheaxose (X6). We did not see a change in the peaks 
identified as possible xylotetraose and xylopentaose peaks. At this time these peaks have 
been only identified preliminarily as xylodextrin peaks, since the retention times of the 
xylodextrins seem to be shifted when in the hydrolysate. For this reason, only the peak 
areas are plotted, rather than the xylodextrin concentrations, however, there is a clear 
difference between the NC5 strain without the plasmids and that with the xynTB-
containing pLOI3708. This result combined with the microplate study just discussed 



















(+) xylose 5 g/L 
(-) M9 no sugar 
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genes are expressed. Other methods which will be used in the future to confirm the 
xylodextrin consumption are discussed below. 
 
 
Figure 3.17 Xylodextrin utilization of the NC5 pLOI3708 strain on 75% hydrolysate. (A) Growth profile 
and utilization of xylobiose (B), xylotriose (C) and xylohexaose (D) on 75% CS hydrolysate. Results are 
shown for the NC5 strain with no plasmids incorporated and the NC5 pLOI3708 (two biological 
replicates). Peak areas are shown for the xylodextrins instead of concentrations. HPLC results are from the 
Rezez-RSO oligosaccharide column.  
 
3.5 Discussion and conclusion 
In conclusion, we have designed a two-member E. coli consortium that is capable 
of converting hexose and pentose monosaccharides (and potentially pentose 
oligosaccharides) into isobutanol. We have shown that the co-culture of a five- and six-
carbon specialist (NC5/NC6) produces higher titers of isobutanol than a diauxic strain 
(NC6) under the same conditions (6.57 vs. 5.8 g/L), at a yield of about 82% of 
theoretical. We have also demonstrated that this co-culture grows well on AFEX-
pretreated corn stover (CS) hydrolysate and produces almost up to 3 g/L isobutanol (at 
~65% of the theoretical yield) without supplementation, and that diluting this hydrolysate 
with diH2O increases titers and improves growth (Figure 3.15). This work addresses 
some of the remaining challenges that remain in the conversion of lignocellulosic 
feedstocks to next-generation biofuels: complete utilization of five-carbon sugars and 
achieving high titers on actual biomass as opposed to defined laboratory media. 
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It is important to consider our results in the context of other isobutanol production 
schemes. In terms of overall titers on defined media, ours are much lower than that 
obtained by Baez et al. (67), which used a gas stripping mechanism for isobutanol 
removal from a much larger 1 L bioreactor. Since isobutanol is toxic at about 7-8 g/L 
(67) high titers of isobutanol are unlikely to be achieved without some mechanism to 
remove the product. If we compare our process with other work using the same strain in 
250 ml shake flasks on defined media, we again see that our titers are lower, but are 
yields are comparable or even higher. In previous work with the NV3 strain, it was 
reported to produce 8 g/L after 24 hours with no glucose feeding and 13.6 g/L after 99 
hours with glucose feeding, achieving an isobutanol yield of 0.24 g/g (productivity 
0.0024 g/L/h, calculated from (63)), vs. our yield of 0.33 g/g after only 48 hours. This 
shows that our co-culture process is more efficient with regard to isobutanol yield. We 
could increase the titer by feeding more sugar as in these other processes, however, in our 
experiments the sugar was not completely consumed, so it is not clear that feeding cycles 
would further increase the isobutanol titer in our case. 
In selecting a promising base strain for the C5 and C6 specialists, we examined 
the isobutanol production and yields of various isobutanol producers, such as JCL60, 
NV3, and NV3r1 (62, 63) under our preliminary culture conditions. Although in previous 
work the JCL260 strain exhibited the highest isobutanol yield, and the NV3r1 strain the 
highest isobutanol titer under the same conditions (63), in our hands the NV3 was the 
least variable and produced the highest isobutanol titer when grown on xylose, suggesting 
that it would make a good C5 specialist (data not shown). For these reasons we chose the 
NV3 as our base strain over the JCL260 or NV3r1. Differences between our culture 
conditions and those of the previous study (feeding cycles, induction time, etc.) may have 
contributed to the exhibited differences in the best producer. Additionally, we used 
plasmids pSA55 and pSA69, whereas plasmids pSA65 and pSA69 were used in the 
previous study (63). Since pSA65 contains a better ADH enzyme, AdhA from L. lactis, 
(66), this will certainly affect the final titers achieved and each ADH may perform 
differently depending on the host strain. Switching from pSA55 to pSA65, therefore, may 
be one way to further increase our titers, as this enzyme has shown better production than 
ADH2 is previous work (66). 
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We observed much variability in isobutanol production, especially with the NC6 
and NC5+NC6 cultures. We hypothesized that most of this variability was due to plasmid 
loss during the fermentation, as plate counting revealed that the cells often lost the larger 
pSA69 plasmid in defined medium. A possible solution to this problem could be to 
supplement antibiotics throughout the co-culture growth, however this would not be 
useful in an industrial setting due to the cost and would increase the chance of 
contamination. We could instead move the plasmid-borne genes onto the chromosome 
using λRed phage recombination or a similar method. This would likely need further 
optimization as the chromosomal expression level of these genes (which corresponds to 
one copy) would then be much lower than that on multi-copy plasmids. 
Although our process is aerobic, we did observe some fermentation byproduct 
formation in the NC5, NC6, and NC5+NC6 cultures, perhaps as a result of oxygen 
depletion during the course of growth. The cultures were grown at a volumetric flask to 
culture ratio of at least 5:1 and the flasks were opened every 12-24 hours to retrieve 
samples (the ratio would increase over time due to decreases in culture volume as a result 
of sampling). As shown in Figure 3.18 below, for the fermentation with 36 g/L of each 
sugar (72 g/L total) a significant amount of ethanol was produced in the monocultures 
and co-cultures, as well as some acetate and succinate. These byproducts may have led to 
the cessation of growth and lessened overall isobutanol titers. Since the flasks must be 
closed to prevent isobutanol evaporation, the best way around this problem is to eliminate 
the pathways for byproduct formation, as demonstrated previously (62). This can be 




Figure 3.18 Byproduct formation on M9IPGX+YE 36 g/L each sugar (72 g/L total). Only one biological 
replicate is shown for each culture. 
In contrast to our chosen aerobic system, the maximum isobutanol yield would be 
obtained via an anaerobic process (80). This is not possible with the current setup, as two 
enzymes in the pathway (IlvC and ADH) require the cofactor NAD(P)H which cannot be 
regenerated anaerobically (80). To resolve this issue, in a recent article by Bastian et al., 
the IlvC (ketol-acid reductoisomerase) was engineered via evolution and targeted 
mutagenesis to use the cofactor NADH instead of NAD(P)H (80) which is generated via 
glycolysis. By combining this engineered enzyme with another version of the alcohol 
dehydrogenase that can utilize NADH (LdhA from L. lactis) isobutanol production at 
100% of the theoretical maximum under anaerobic, NADH-producing conditions, was 
achieved (80).  To improve our system, we could then utilize these enzymes in place of 
the IlvC on plasmid pSA69 and the ADH on plasmid pSA55, and convert our setup to an 
anaerobic process. This would likely change our results and experimental process a great 
deal. 
An obvious next step for our system is to combine the NC5 pAK6/pSA69 strain 
with the NC6 and grow these in co-culture on the hydrolysate. From preliminary 
cultivations on the diluted hydrolysate it is not clear whether or not the addition of the 
xynTB genes allows for increased isobutanol production. This may be due to the high 
concentration of xylose that still remains unutilized at the end of the cultivation. Also, 
there will likely be several rounds of optimization necessary in order to see acceptable 
results. Utilization of the xylodextrins should also be confirmed with other methods 
besides HPLC, since we have observed that the retention times of the xylodextrins seem 





























chromatography (TLC) (81), which has been used in the past to measure the consumption 
of xylodextrins (74). Additionally, we could do an acid hydrolysis of the culture 
supernatants before and after cultivation to measure the total oligosaccharide content. 
This method, however, would not identify the usage or presence of individual 
oligosaccharides. 
Lastly, we would like to combine these two E. coli specialists with a fungal 
cellulolytic specialist, Trichoderma reesei, to create a truly “one-pot” production system 
whereby the fungus acts in place of the enzyme mixture to break down the corn stover 
directly into fermentable sugars. This idea is discussed further in the Future Directions, 
Section 5.2.2.  
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Chapter 4  Use of microbial consortia in high-throughput 
screening for over-production of L-valine and isobutanol  
4.1 Summary 
In this work, we have designed a two-member microbial consortium consisting of a 
secretor-sensor pair to detect highly-secreting L-valine production strains. This will be 
part of a larger effort to develop a new high-throughout screening (HTS) method for 
automated production strain development and identification. We have identified a partner 
strain that exhibits synergistic growth with the L-valine auxotroph, ΔpanB, a pantothenate 
auxotroph. We then engineered a secretor “proof-of-concept” strain with mutation 
capabilities incorporating several mutations for L-valine over-production (panB-, ilvNfbr), 
and demonstrated that when grown with the L-valine auxotroph the co-culture growth is 
increased with panB deletion, however additional secretor strain characteristics that are 
beneficial for engineering mutations (such as mutS-) may overshadow growth benefits 
conferred on the L-valine auxotroph (the sensor strain, ΔilvE). The composition of the co-
culture, however, is altered to favor the sensor strain, indicating increased L-valine 
secretion. We also investigated optimal conditions for growth by titrating the 
concentration of L-leucine that is added to the medium. 
The materials presented in this chapter will be reported as part of a future 
manuscript: Kerner A, Park J, Minty J, Rossion M, Burns MA, and Xiaoxia (Nina) Lin. A 
high-throughput screening system for microbial overproduction based on cross-feeding 
and droplet cultivation. 
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4.2 Introduction 
4.2.1 High-throughput microbial screening techniques 
Traditional methods of strain engineering – rational design and random 
mutagenesis – are time-consuming and extremely low-throughput, and do not allow for 
vast combinatorial interactions to be easily investigated (82, 83). However, recent 
advances in high-throughput genome engineering (84-86) have brought about the need 
for much faster and more efficient screening techniques in order to utilize the large 
mutant libraries generated through automation (83). There exist various screens for easily 
detectable, colorimetric products, but so far traditional methods of detecting small 
molecules, such as gas chromatography or mass spectrometry, lag far behind the 
advances in strain development in time and scope--current library screening size is about 
1000 mutants (82). There is a critical need, therefore, for high-throughput screens that are 
fast, can handle large numbers of variants, can detect low concentrations of non-
colorimetric molecules, and ideally are not molecule-specific. Especially lacking are 
screens that detect actual secretion of desired small molecules. A possible solution to this 
problem are biosensors (82), which can convert the undetectable molecules into readable 
outputs (Figure 4.1). In particular, “whole-cell” biosensors are useful for detecting 
secretion of desired compounds, one of which we have designed and constructed in this 
work.  Following is a brief discussion of various recent advances with regard to microbial 
detection of small molecules.    
 
Figure 4.1 Different types of biosensors, adapted from (82). Small molecule A is detected intracellularly by 
conversion into a reporter protein, extracellularly by import into the cell, or intracellularly by activating 
transcription of a reporter protein. 
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Earlier examples of microbial screens used colorimetric assays to detect 
production of desired compounds. One interesting example is the use of a tyrosinase to 
couple the over-production of tyrosine to that of melanin, which is a brownish-black 
pigment that can be easily detected by visual inspection (87). Cells that carry a plasmid 
carrying a mutant melA gene (encoding the tyrosinase) would turn brown when also 
producing large amounts of tyrosine. After creating a random knockout library, 
production strains carrying the tyrosinase were visually selected on agar plates and then 
subcultured for two rounds at 120 - 144 hours each to allow for melanin synthesis. After 
subculturing and plasmid-curing of the tyrosinase vector, two mutants were isolated that 
produced up to 57 and 71% more tyrosine than the base strain (87). While this example 
highlights the simplicity of colorimetric assays, it also illustrates the low-throughput 
nature of visual inspection and is also time-consuming (in part due to the nature of the 
melanin synthesis process). 
More recently, several studies have used transcriptional regulators coupled with 
fluorescence-activated cell sorting (FACS) to detect small-molecule production 
intracellularly (88, 89). Single-cell intracellular detection of metabolites was 
demonstrated through the use of a lysine-responsive promoter in front of a reporter 
protein, YFP, which allowed mutant lysine over-producers to be identified and detected 
using FACS, and then sorted (89). However, direct processing of the mutant library was 
not possible using FACS alone, and the post-processing isolation of mutants took over 
two days. Also, intracellular detection of lysine production resulted in two groups of 
strains being identified, those that synthesized and exported a large amount of lysine and 
those that exhibited large amounts of fluorescence but did not have a high extracellular 
concentration of lysine. This second group may be false positives or may produce higher 
amounts of lysine but not export it. This issue can be avoided by detecting the 
extracellular metabolite concentration, or metabolite secretion, instead of cytosolic 
concentrations. While it can be argued that some producers might be missed via this latter 
method, if the cells cannot secrete the desired metabolite then they will not very useful on 
an industrial scale. Also, as in our case, some metabolites and byproducts would be toxic 
if accumulated intracellularly in high amounts. 
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In a similar work, the transcriptional regulator Lrp of Corynebacterium 
glutamicum was used as a biosensor to detect intracellular concentrations of L-methionine 
and other branched-chain amino acids by placing a fluorescent readout protein (YFP) 
behind the promoter PbrnFE which binds the Lrp-amino acid complex (88). When 
exogenous dipeptides were added to the system, a linear fluorescent response was 
observed via FACS and the minimal detection limit was in the millimolar range, suitable 
for detection of physiological amounts of small molecules (88). The biosensor was also 
used for the detection and sorting of L-valine production strains that had been generated 
by random mutagenesis. As demonstrated in Figure 4.2, cells were mutagenized and then 
cultivated in tubes, sorted, enriched via FACS (up to 10,000 cells/sec), and then screened 
on agar and microtiter plates. The amounts of amino acids produced were analyzed by 
HPLC. The top five mutants selected produced from 4.6 to 8.7 mM L-valine (88). 
Although this sensor has lower rates of false positives than the above report, regions 
where only 2 and 6% of fluorescent cells actually produced increased amounts of L-valine 
were still identified by FACS as fractions of over-producers (Figure 4.2C). Additionally, 
this system suffers from the same problem as the previous biosensor of not actually 
detecting secretion of the desired metabolite and it also takes several days to enrich and 
select for strains that show increased production. The amount of branched-chain amino 
acids that were excreted is not very high, which may be due to the fact that the sensor is 
selecting for intracellular accumulation and not extracellular. 
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Figure 4.2 High-throughput screening approach used in (88). (A) Cells were mutagenized, sorted, re-
cultivated and re-sorted, and then screened by agar plates and cultivated on a microtiter plate. (B-C) 
Changes in YFP levels after re-sorting and cultivation. (D) Percentage of positive clones shown in white, 
>2mM in grey, and viability in black. 
Designing mutations rather than random mutagenesis avoids the decrease in cell 
viability associated with mutations in essential genes and may reduce the library size 
required to see significant increases above baseline (82), which may have been a problem 
in both of the previous single-cell studies. On the other hand, our consortia method may 
not make these deficiencies immediately apparent, as the sensor strain may complement 
some auxotrophies, however it is likely that we would obtain more viable cells since we 
will be able to direct the mutation to specific target genes. 
There has been at least one example of a microbial pair used as a biosensor, in 
this case for detection of mevalonate (90). An E. coli mevalonate auxotroph was 
engineered by introducing a heterologous pathway to convert exogenous mevalonate to 
isopentenyl pyrophospahte (IPP) and dimethylallyl pyrophosphate (DMAPP), which are 
necessary for growth, after removing the native IPP and DMAPP synthesis pathways. 
Therefore, the cell could only grow if exogenous mevalonate was supplied--this strain 
was also tagged with GFP, and was used as the biosensor strain. Next this biosensor was 
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grown on the spent media from cultures of various mevalonate producers in 96-well 
plates. The entire process took about 1.5 - 2 days to first grow the producers, and then to 
grow the sensors on the spent media for mevalonate detection. Out of 600 pre-screened 
clones, 18% showed fluorescence that was significantly higher than baseline and four 
clones were eventually identified with 7X more mevalonate production than the baseline 
(90). While this is a very significant result in terms of production strain isolation, it is not 
very high-throughput since only 96 clones can be screened at once and also takes more 
than a day to grow up the producing strains. Also, it is not clear how much the pre-screen 
contributed to the selection of the high-producers. Growing the sensing strain and 
production strain in co-culture might be one way to decrease the screening time. 
4.2.2 Detection of L-valine and isobutanol production using a secretor-sensor pair 
We propose to detect secretion of the amino acid valine by employing two cross-
feeding auxotrophs, one of which will be a L-valine auxotroph (the “sensor”) whose 
growth will depend on the level of L-valine excreted by the “secretor” strain, here a 
pantothenate auxotroph (see Figure 4.3, a more complete description of the strains 
follows in the Results, Section 4.4.3). In contrast to the aforementioned work, the 
auxotrophs will be grown together in co-culture, allowing rapid detection of the amount 
of extracellular L-valine in the form of a growth response by the sensor. We predicted 
that increased L-valine production and export by the secretor strain would increase the 
growth rate of the co-culture as a whole, and possibly the fraction of the sensor as well, 
which can be distinguished by tagging with constitutively-expressed fluorescent protein 
YFP. This has been previously demonstrated in the previously described work and in our 
first project, where increased growth rate and/or ratio could be determined using 
fluorescent (FL) readout (19, 90). 
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Figure 4.3 Schematic of the secretor-sensor pair. The sensor, a L-valine auxotroph (ΔilvE), secretes 
pantothenate for the secretor, a pantothenate auxotroph (ΔpanB), and vice versa. The sensor is tagged with 
a fluorescent protein, base strain BW25113. The secretor base strain is EcHW24 (84), a “mutator” strain 
with λRed homologous recombination capabilities. 
The reason we are particularly interested in L-valine production is its link with 
isobutanol production, as described above in Section 3.2.2 (a schematic is shown in 
Figure 4.4). To briefly reiterate, the L-valine biosynthesis pathway produces 2-
ketoisovalerate from pyruvate, which is then converted into L-valine (64). The final steps 
in the Erlich pathway were used to convert 2-ketoisovalerate into isobutanol using a 2-
keto acid decarboxylase (KDC) and alcohol dehydrogenase (ADH) introduced into E. 
coli isobutanol production strains that were constructed via rational design (61) or 
evolution and random mutagenesis (63). It was demonstrated in the evolutionary 
approach, which selected for increased growth on a L-valine analog, norvaline, that 
increased secretion of L-valine does, in fact, correlate to increased isobutanol production 
once the plasmids containing the KDC and ADH have been introduced (63). For this 
reason, we predict that combining the mutations found by the random mutagenesis 
approach with those that have been shown to increase valine production via rational 
design (64) (discussed further below) will produce mutants that can secrete large amounts 
of L-valine and isobutanol. 












Figure 4.4 Schematic of the pyruvate to L-valine and isobutanol pathway created by the addition of the 
plasmid-borne kivd and adhA genes. The branch point between isobutanol and valine is highlighted. 
Adapted from (63). 
To convert this microbial detection system into a high-throughput process for 
overall strain development and screening, we plan to use methods such as the recently-
developed genome manipulation technique Multiplex Automated Genome Engineering, 
or MAGE (84), to simultaneously and rapidly introduce various mutations throughout the 
secretor chromosome, creating a large library of variants that secrete various levels of L-
valine. Then we plan to cultivate the secretor mutants with the sensor strains in droplets 
on a microfluidic device. A diagram of the entire process is shown in Figure 4.5. The 
device will allow us to isolate one pair per droplet, and after cultivation, to sort the 
droplets by their level of growth (i.e. fluorescence). The strains can then be tested off-
chip to confirm that those that have faster-growing pairs do indeed contain secretor 
strains that produce more L-valine, and hopefully, isobutanol, once they are transformed 
with the relevant KDC- and ADH-containing plasmids.  
Here we discuss the design and construction of a proof-of-concept microbial 
secretor/sensor pair and demonstrate that by introducing a few preliminary mutations that 
have been known to increase valine production, the secretor strain is able to compensate 
for the valine auxotrophy. Also, the co-culture composition changes to indicate increased 
valine secretion, however growth defects may overshadow the growth rate benefit from 




Figure 4.5 Proposed method for high-throughput production strain development and screening utilizing the 
microbial consortium as a secretion detection mechanism. 
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4.3 Methods 
4.3.1 Microplate growth studies for auxotroph selection and leucine titration 
For the microplate cultivations to determine the best secretor base strain, mono- 
and co-cultures were cultivated in minimal M9 medium with 0.2% glucose as a carbon 
source. L-Leucine and L-isoleucine were added to a final concentration of 2 mM unless 
otherwise indicated. L-valine was added to a working concentration of 150 mg/L where 
indicated, and sodium pantothenate to 1.5 mM. No antibiotics were added to the medium. 
Frozen stocks were inoculated into rich LB medium with 30 µg/ml kanamycin and grown 
overnight to saturation, then washed twice with minimal M9 medium. For the auxotroph 
determination, Keio collection (43) strains were used in all experiments. The strains used 
were: ΔilvE (JW5606-1), ΔpanB	   (JW0130-1), ΔpanD (JW0127-2), ΔproC (JW0377-1), 
ΔtrpE (JW1256-1), and ΔpheA (JW2580-1). Cultures were then diluted by 1:100 and 
pipetted onto a 96-well microplate (Costar) to a volume of 200 µl per well. Unless 
otherwise stated, four replicates were conducted per microplate sample. Cultures were 
grown for 48 hours at 37 oC on an VersaMax (Molecular Devices) plate reader with 
shaking and OD600 measurements were taken every 15 minutes.  
4.3.2 Secretor and sensor strain construction 
The Keio collection mutant BW25113 ilvE::kan (Keio collection strain JW5606-
1) (43) was used as a base strain for the sensor (L-valine auxotroph, here called ∆ilvE). 
The strain was then tagged with a fluorescent protein, YFP, for visualization of the ratio 
in microplate studies and the growth rate on-chip. The YFP cassette, intC::yfp-cat, was 
inserted into the L-valine auxotroph via P1 transduction. P1 lysates were grown on the 
donor strain DS1-Y (91) and were then mixed with the recipient strain, ∆ilvE, to allow 
infection and recombination.  YFP was integrated into the intC locus with a cat selection 
cassette. This gene is under control of two λPR promoters (44). 
To create the secretor strain, we started with base strain EcHW24 (bioA::λRed-
bla-tet mutS-) which was developed for the specific purpose of ssDNA recombination 
(84). The the pantothenate auxotrophy was then created by inactivating the panB gene by 
inserting two premature stop codons using λRed-mediated ssDNA recombination (86), 
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creating strain EcLSB. The sequence of the oligo for inserting the stop codons is as 
follows, with the mutated bases highlighted in blue:  
panB_stop: 5’-T*A*C*A*AACAGGAAAAAAAACGTTTCGCGACCATCACCGC 
TTAGGACTAAAGCTTCGCCAAACTC TTTGCTGATGAAGGGCTTAACGTCATG-3’.  
The mutations were confirmed via sequencing the panB locus and allele-specific PCR 
(asPCR) (92), as well as via plating on minimal M9+biotin (or “N”) plates. Without 
sodium pantothenate added, the strains did not grow on the minimal plates. 
Next we introduced the following mutations into the ilvN gene: G59A, C60T, 
T62A, A63C, A64T, G66C (corresponding to amino acids substitutions: G20D, V21D, 
M22F) again using ssDNA recombination mediated by the λRed proteins, creating 
EcHW24 panB- ilvNfbr, or EcLSBN. The oligo used was:  
ilvN_fbr_mut:	  5’-T*C*A*A*CGTTAAAAGCGCGGCGGGCAAAAAGGCCACAAACGT 
GGGTGAAGTCATCCGGATGGTTGCGAACGGTGAGCTCCAGAATTACGTTG-3’ 
The mutations were confirmed by asPCR and by sequencing the ilvN locus. 
4.3.3 Microplate growth cultivation with the secretor/sensor pair and ratio 
determination via plate counting 
For the microplate experiments with the EcLSB and EcLSBN strains, mono- and 
co-cultures were cultivated in minimal N medium (M9 + biotin) with 0.2% glucose as a 
carbon source. L-valine was added to a final concentration of 150 mg/L where indicated, 
and sodium pantothenate to a concentration of 1.5 mM. No antibiotics were added to the 
medium. Frozen stocks were inoculated into rich LB medium with 50 µg/ml ampicillin 
for EcLSB/EcLSBN and 30 µg/ml kanamycin for ΔilvE and grown overnight to 
saturation. Cultures were then diluted by 1:100 in N medium and pipetted onto a 96-well 
microplate (Costar) to a volume of 200 µl per well. Unless otherwise stated, four 
replicates were conducted per microplate sample. Cultures were grown for 72 hours at 30 
oC (so as not to induce the temperature-sensitive λRed proteins) on an M5 (Molecular 
Devices) plate reader with shaking. OD600 measurements were taken every 15 minutes. 
The co-culture composition was determined via differential plate counting. At 72 hours, 
the cultures were diluted by 1x104 and 50 µl was plated on N + 2 mM sodium 
pantothenate plates (to select for the pantothenate auxotroph, contains biotin) and on M9 
+ 150 mg/L L-valine + 2 mM L-isoleucine plates (to select for the valine auxotroph). The 
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colonies were then counted after two days of incubation at 30 oC to determine the co-
culture ratio at the end of cultivation. 
 
4.4 Results and Discussion 
4.4.1 Selection of a secretor base strain and microplate studies 
In order to create a L-valine auxotrophy, the branched chain amino acid 
transferase-encoding gene, ilvE, was replaced with the kanamycin reisistance cassette in 
strain BW25113 (Keio collection strain JW5606-1, CGSC). This L-valine auxotroph, the 
sensor strain, is paired with another auxotrophic strain to create the metabolic 
dependency. It would be beneficial to find a suitable partner strain by looking for 
auxotrophs that grow well with the L-valine-deficient strain, since increased growth will 
be our metric for increased L-valine production. A good place to begin the search for a 
partner strain is previous data on the growth of auxotroph pairs, illustrated in Figure 4.6 
below (93). In this work, various auxotrophs were grown together in minimal media to 
identify synergistic mutations (specifically, knockouts), by looking at the increase in co-
culture growth over the baseline for either strain or for the pair (indicated by either red, 
blue, or purple in the heat map below, and inset). The results for the L-valine auxotroph 
(ilvE) when it is the mCherry-tagged partner strain are highlighted in yellow.  
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Figure 4.6 Heat map of synergistic interactions between auxotrophs, adapted from (93) to highlight the 
beneficial interactions for the valine auxotroph, ilvE, outlined in the yellow box. Red denotes increased 
growth of strain A, and blue denotes increased growth of strain B. The colors should be opposite and 
symmetrical about the diagonal. 
From the above plot, we selected eight partners to test with the valine auxotroph 
in microplate studies, and then narrowed these down to the five with the highest growth 
rate and/or maximum optical density (OD600) values: ΔpanB, ΔpanD, ΔproC, ΔtrpE, 
ΔpheA. Keio collection knockout strains were used in all microplate growth experiments 
(Methods). Several of these knockout are intuitive: knocking out panB, which encodes3-
methyl-2-oxobutanoate and causes pantothenate auxotrophy, has been shown to increase 
valine production (64) and a proC point mutation (A98T) was also discovered in the 
norvaline-resistant mutant NV3 (Appendix Table 1, 63). To ensure that any increases in 
growth are due to complementation of the valine auxotrophy and not to other 
auxotrophies caused by removal of the IlvE protein, we added L-isoleucine and L-leucine 
to the growth medium (2 mM each). However, the valine auxotroph was able to grow on 




Figure 4.7 Growth rate (top) and maximum optical density (bottom) for the five auxotrophic pairs and 
control strains. Strain K12 MG1655 is used as a control. Error bars show the ± standard deviation of three 
replicates. 
Microplate experiments with the auxotroph pairs in minimal media indicated that 
either ΔpanB or ΔtrpE would be the best growth partner for the L-valine auxotroph, 
ΔilvE. ΔtrpE + ΔilvE had the highest growth rate in minimal medium with L-leucine at 
0.21 ± 0.01 1/hr, though all were fairly low. Without L-leucine, ΔproC + ΔilvE exhibited 
the fastest growth rate at 0.25 ± 0.01 1/hr, but the lag time was much longer with this 
pair, which is not reflected in the plots. ΔpanB + ΔilvE grew to the highest maximum 
OD600 with L-leucine added at 0.39 ± 0.05 a.u. which was significantly higher than the 
rest of the cultures (Figure 4.7). Without L-leucine, ΔpanB + ΔilvE also grew to the 
highest maximum OD600 though this value was not much larger than several of the other 































































































































out this gene has been known to increase valine production by shutting down formation 
of pantothenate (64). 
We noticed that adding L-leucine sometimes negatively affected growth in the co-
cultures and with the positive control, K12 MG1655 (see Figure 4.7 above). This may be 
due to the antagonistic affect of the transcriptional regulator leucine responsive protein 
(Lrp) when bound to excess L-leucine (94). The Lrp regulon is quite varied, including 
pathways for amino acid biosynthesis (depicted in Figure 4.9 below), degradation, 
transport, and pilin synthesis, and can act as a transcriptional activator or repressor 
depending on the operon and cellular conditions (94). For example, Lrp normally 
activates the ilvIH genes, but when L-leucine is present it antagonizes this activation.  
Because of this, we investigated titrating the L-leucine concentration via 
microplate experiments to determine the optimal concentration of L-leucine for the 
growth and production of L-valine. As shown in Figure 4.8A, increasing the L-leucine 
concentration decreases the growth rate even for the control strain, K12 MG1655. The 
fastest co-culture growth rate was observed with the ΔpanB + ΔilvE strains and 0.2 mM 
L-leucine (0.38 ± 0.02 1/hr). A slightly higher maximum optical density at 600 nm was 
observed for the co-culture with 0.6 mM L-leucine, however it was not significantly 
better than either 0 or 0.2 mM L-leucine (Figure 4.8B). Since the lag phase for 0.2 mM 
was longer than either 0.6 mM (Figure 4.8C), on-chip this might not be best 
concentration since we will want to determine the cultures with the highest level of 
growth (fluorescence) at a particular point in time. Therefore, the optimal concentration 
will probably be somewhere between 0.2 and 0.6 mM. These experiments will be 
repeated with the final permutations of the secretor and sensor base strains before 
performing the automated mutant library generation (i.e. MAGE). 
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Figure 4.8 Leucine titration in microplate growth experiments. (A) Growth rate (1/hr) and maximum 
optical density at 600 nm (B) for the K12 control strain and the ΔpanB+ΔilvE or ΔilvE cultures with 
varying amounts of L-leucine. The ΔilvE monocultures did not grow out and so a growth rate was not 
calculated. (C) The growth curves for the ΔpanB+ΔilvE co-culture show large variation with 0.2 and 2mM 
L-leucine and a much longer lag phase with 2mM. Data shown is the average of three biological replicates. 
 
4.4.2 Identification of target mutations for L-valine over-production 
Over-production of L-valine and the other branched chain amino acids (BCAAs), 
L-leucine and L-isoleucine, has been very well-studied and annual production levels are 
currently around 400-500 tons (95). These amino acids may be used in various 
applications such as in animal feed (95) and as precursors for antiviral drugs and 
herbicides (88), so there has been much interest in their large-scale production (64, 96-
98). There are therefore various reports in which we may find favorable mutations that 
we can use to create a L-valine and isobutanol over-producer. 
A schematic of the L-valine and BCAA biosynthesis pathway is shown in Figure 
4.9, which includes mutations that were introduced in the rational design methodology 
from (64). The BCAA synthesis from pyruvate begins with three acetohydoxy acid 
synthase isoenzymes (AHAS I, II, and III) encoded by ilvBN, ilvGM, and ilvIH which are 
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the sites of each enzyme’s catalytic activity (encoded by ilvB, ilvG, and ilvI) (96) whereas 
two of the smaller subunits (ilvN and ilvH) contain known sites for feedback inhibition. 
Excess L-valine and L-leucine can inhibit AHAS I and III production through 
transcriptional attenuation of the ilvGMEDA and ilvBN operons; the former can also be 
regulated by L-isoleucine as well (94-96). L-Valine can also allosterically inhibit these 
enzymes by binding to sites in the ilvH (64) and ilvN (96) genes (see Figure 4.9). The 
ilvGM protein AHAS II is not normally expressed in E. coli due to a frameshift mutation 
in ilvG, and this can lead to what is referred to as “valine toxicity” (95).  If L-valine is 
over-expressed, it will inhibit expression of the AHAS I and III, causing an excess of 2-
ketobutyrate, which is toxic to the cells. For this reason it is important to mutate either the 
ilvN or ilvH genes as one of the first steps when attempting to over-produce L-valine. 
Park et al. were able to achieve high titers of L-valine in shake flasks by 
introducing mutations to relieve feedback inhibition and transcriptional attenuation, as 
well as remove byproduct formation by knocking out competing pathways (Figure 4.9) 
(64). First, feedback inhibition in the ilvH gene was removed by inserting the point 
mutations G41A and C50T. Next, transcriptional attenuation was removed by placing the 
chromosomal ilvGM and ilvBN genes under control of the tac promoter. To reduce 
formation of competing byproducts, the ilvA, panB, and leuA genes were knocked out, 
which encode enzymes that participate in L-isoleucine, pantothenate, and L-leucine 
synthesis, respectively. For over-expression of key enzymes in the biosynthetic pathway, 
ilvBNCED were cloned onto a plasmid, again behind the tac promoter. Lastly, since the 
protein Lrp was found to be down-regulated via transcriptome analysis, likely due to the 
addition of L-leucine to the medium, it was also placed on a separate plasmid for over-
expression along with the putative valine exporter ygaZH (64) (Figure 4.9). As discussed 
above, Lrp activates transcription of the ilvIH genes (94) and also plays a role in 
activating ygaZH expression (a valine exporter) (64). This strain (Val pKBRilvBNCED, 
pTrc184ygaZHlrp) was able to produce up to 7.61 ± 0.24 g/L L-valine on 50 g/L glucose, 
an increase of 113% over the control strain (64). 
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Figure 4.9 Pathway for synthesis of L-valine and the other BCAAs, adapted from (64). Knockouts are 
shown by gray bars, increased flux is indicated by thick red arrows. Thick blue arrows are inhibition by 
Lrp. Mutations in the ilvH gene are listed. Additional sites of L-valine inhibition in ilvN are not shown. 
In the same report, three other genes (aceF, pfkA, and mdh) were identified for 
removal by in silico gene knockout analysis, giving strain VAMF. Although VAMF 
produced more L-valine in 20 g/L glucose media than the previous Val strain (both with 
the plasmids added), these last three mutations decreased the growth rate of the strain 
significantly. Therefore for our purposes these last three knockouts may not be as useful. 
More recent work by the same group introduced a feedback-resistant ilvN gene with 
amino acids substitutions G20D, V21D, and M22F, which conferred resistance to 
increasing amounts of L-valine (98). Similar mutations had previously demonstrated 
increased resistance to all three BCAA’s and increased L-valine production in C. 
glutamicum (96). In the previously described Val strain, incorporation of the feedback-
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resistant ilvN (Val pKBRilvBNfbrCED, pTrc184ygaZHlrp) resulted in 18.4 g/L L-valine 
being produced, a 22% increase over the control strain (98). 
4.4.3 Design of secretor and sensor strains 
Our end goal is to select around 30-40 mutations from both the rational design 
methodologies mentioned above, as well as the evolutionary study performed by Smith et 
al. (63) that we will then introduce into our secretor base strain in a combinatorial manner 
using techniques for automated genome library generation. We predict that there will be 
various benefits that may arise from the combinatorial interactions between some of these 
mutations, which we would not otherwise have come across from rational design. In 
order to demonstrate the utility of using a microbial consortium as a secretion detection 
mechanism, we will first introduce a set of preliminary mutations into the secretor base 
strain EcHW24 (84) to increase L-valine production (genotype bioA::λRed-bla-tet mutS-). 
Once we chose the pantothenate auxotroph as the partner for the sensor strain, we 
first re-created the pantothenate auxotrophy in the EcHW24 strain by inactivating the 
panB gene via the insertion of two premature stop codons using λRed-mediated ssDNA 
recombination (86) (Methods). To determine the second proof-of-concept mutation, we 
looked at the most favorable mutations from the previous reports (64, 98). Since we did 
not know the benefit of each of the mutations that resulted from the evolution and 
random mutagenesis study by Smith et al. (63), we looked to the rational design 
methodology first. Below is a table showing some of the mutations that either occur early 
on in the synthesis pathway or result in a large increase in L-valine production (Table 
4.1). For some mutations there were no data available on the increase in L-valine due to 
that mutation alone. Since the efficiency of recombination is greater with a point 
mutation than an insertion or deletion when using the ssDNA recombination system (84), 
and since excess L-valine is “toxic” to the cells unless the feedback inhibition is removed 
for either AHAS I or II, we decided to mutate one of these enzymes first. The AHAS I 
has a greater affinity for pyruvate than AHAS III (95), which has a higher affinity for 2-
ketobutyrate, so we decided to try mutating this gene first since that would lead to more 
L-valine production rather than L-isoleucine. We introduced the following mutations into 
the ilvN gene: G59A, C60T, T62A, A63C, A64T, G66C (corresponding to amino acids 
 97 
substitutions: G20D, V21D, M22F) again using ssDNA recombination mediated by the 
λRed proteins, creating EcHW24 panB- ilvNfbr, or EcLSBN. 
Table 4.1 Various mutations to increase valine production and the level of increase, if available. ND: no 
data. 
Gene	   L-Valine	  increase	   Mutation	  type	   Notes	   Reference	  
ilvH	  
(AHAS	  III)	   ND	  
Point;	  G41A,	  
C50T	  
Relieves	  allosteric	  inhibition,	  but	  still	  




(AHAS	  I)	   22%	  
Point;	  G20D,	  
V21D,	  M22F	  (aa)	  
May	  create	  a	  lot	  of	  acetic	  acid	  
Higher	  affinity	  for	  pyruvate	   (98)	  
aceF	   2X	  (100%)	   deletion	   May	  slow	  secretor	  growth	   (64)	  
ygaZH	   47.1%	   Over-­‐expression	   Putative	  valine	  exporter	   (64)	  
 
To create the base sensor strain, we started with the Keio collection mutant ΔilvE 
(Methods). We then tagged the strain with a fluorescent protein, YFP, for visualization of 
the ratio in microplate studies and the on-chip growth rate. The YFP cassette, intC::yfp-
cat, was inserted into the L-valine auxotroph via P1 transduction (Methods). Preliminary 
growth studies with these strains are discussed below. 
4.4.4 Preliminary growth studies with the proof-of-concept strains 
After constructing the secretor and sensor strains with the preliminary mutations, 
we grew the strains in mono- and co-culture on the microplate to examine the growth rate 
changes and changes in composition (Figure 4.10). In this experiment the sensor strain 
(ΔilvE) does not contain YFP. The different strains used were the Keio collection 
pantothenate auxotroph, ΔpanB, and the EcHW24-derived strains EcLSB and EcLSBN. 
When paired with all three secretors the sensor strain can grown in N medium without 
valine added, demonstrating that the deletion of panB function can compensate for the 
valine auxotrophy in the sensor. However, to our surprise, the lag time is still quite long 
with the ilvNfbr mutations incorporated, and the co-culture growth rate is slower for 
ΔilvE paired with EcLSBN than either of the other pantothenate auxotrophs without ilvN 
mutated (ΔpanB or EcLSB, Figure 4.10B). This was rather unfortunate, as we had hoped 
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to use the increase in growth rate to monitor the rate of cross-feeding. However, since the 
EcLSB + ΔilvE co-culture does not exhibit the same growth dynamics as the ΔpanB + 
ΔilvE co-culture, the problem may be with the parental EcHW24 or something that 
occured when inserting the premature stop codon into panB. Since EcHW24 contains the 
mutS- genotype, it is prone to mutations and may have incorporated a deleterious growth 
mutation. It also contains the λRed cassette, which we have found can significantly 
decrease the growth rate (data not shown). When pantothenate is added to the medium, 
the strain grows but does not grow as well as the Keio strain ΔpanB (data not shown). 
Ideally, we would remove these genes and revert the mutS- genotype after all of the valine 
secretion mutations have been incorporated. 
 
Figure 4.10 Microplate growth results with the secretor and sensor strains. Growth profile over time (left) 
and growth rates of the co-cultures (right). ΔpanB is the Keio collection pantothenate auxotroph. Error bars 
represent the standard deviation from the mean of four biological replicates. No leucine was added to the 
medium. 
Although the growth was slower as more mutations were incorporated, rendering 
the ilvN gene feedback-resistant did increase the ratio of the sensor strain to the secretor 
strain, as evidenced via differential plate counting at the end of the cultivation (Table 
4.2). With the Keio-based pantothenate auxotroph, ΔpanB the sensor:secretor ratio was 
0.647, but with the EcLSBN strain it increased to 3.28, indicating that there may be an 




















!panB + !ilvE  
EcLSB + !ilvE  
EcLSBN + !ilvE 







































Table 4.2 Differential plate count results. Co-cultures were diluted and plated from two wells at the end of 
the above microplate experiment (at 72 hours) on either N (M9+biotin) + sodium pantothenate, or M9 + L-
valine + L-isoleucine plates. The ratio of the secretor: sensor is the L-valine:pantothenate auxotroph. 
Co-­‐culture Ratio	  sensor:secretor	  
ΔpanB	  +	  ΔilvE	   0.647	  
EcLSBN	  +	  ΔilvE	   3.28	  
 
The potential increase in growth rate from increased valine secretion may be over-
shadowed by a growth defect in the EcLSB and EcLSBN strains. A possible solution to 
the problem is to remove the mutS- genotype and/or λRed cassette and see if that restores 
the growth rate. If not, then instead of knocking out the PanB function by inserting a 
premature stop codon, we could try to delete the entire gene using homologous 
recombination or by using P1 transduction of the Keio panB::kan cassette into the 
EcHW24 base strain. The problem with these two methods is that deleting an entire gene 
is less efficient that making a point mutation (84), and that with the P1 transduction a 
FRT scar sequence is left in place of the panB locus. Both methods are also generally 
irreversible. 
The problem may also be due in part to transcriptional attenuation of the ilvN locus 
by L-valine. Although the allosteric inhibition should have been removed, excess L-valine 
can still inhibit the ilvN operon if present in high concentrations (95). To relieve this 
additional inhibition, we could swap out the chromosomal ilvN promoter with an 
inducible promoter such as the IPTG-inducible promoter Plac, or amplify the feedback-
resistant ilvN from the chromosome and place it behind an inducible promoter on a 
plasmid. This second method may be preferable to demonstrate a proof-of-concept pair, 
as this would also increase the copy number of the genes and may be easier to 
accomplish. 
4.5 Future Work 
Our secretor and sensor strains need to be further optimized in order to fully 
demonstrate that the microbial consortium can indeed be utilized detect increased levels 
of L-valine secretion. There may be a growth defect in the EcLSB and EcLSBN strains, 
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which could be solved by removing the mutS- genotype and/or λRed cassette. 
Additionally, instead of making the PanB- phenotype by inserting a premature stop 
codon, we could delete the entire gene using homologous recombination or by using P1 
transduction of the Keio panB::kan cassette into the EcHW24 base strain. The lack of 
observable growth benefits may also be due in part to transcriptional attenuation of the 
ilvN locus by L-valine. To relieve this additional inhibition, we could amplify the 
feedback-resistant ilvN from the chromosome and place it behind an inducible promoter 
on a plasmid. This would be also be beneficial for proof-of-concept demonstration as it 
would increase the copy number of the ilvN gene. 
Additional tube and/or flask experiments should be performed to more accurately 
confirm the growth and composition characteristics and L-valine secretion profiles. The 
isobutanol plasmids can also be incorporated via transformation to determine if the 
increased L-valine secretion does lead to increased isobutanol production with the proof-
of-concept strains. The increased L-valine secretion should also be detected either by 
HPLC or by using a bioassay, where a L-valine auxotroph can be grown on the 
supernatants from secretor strain cultures and then the metabolite concentration 
determined from a calibration curve. Increased isobutanol production can then also be 
measured by HPLC once the pSA55 and pSA69 plasmids are incorporated into the 
system. The change in composition can be monitored via plate counting combined with 
fluorescence measurements. 
Eventually we would like to incorporate the secretion detection pair into a larger 
process for production strain development and high-throughput screening using a 
microfluidic sorting device (as depicted in Figure 4.5). This is discussed further in the 





Chapter 5  Concluding Remarks and Future Directions 
5.1 Concluding Remarks 
5.1.1 Design and construction of a programmable, synthetic E. coli consortium via 
tunable symbiosis 
In this work we have demonstrated the possibility the creation of a tunable, 
microbial consortium that can be “programmed” to provide desired outputs. Our 
symbiotic circuit enables continuous tuning of the growth rate and composition of a 
synthetic, cross-feeding consortium. We developed a basic model to capture the 
dynamics of this consortium, and demonstrated that the growth rate and composition 
could be controlled via manipulating the export rate or synthesis of essential metabolites. 
We implemented our general design through the exchange of tryptophan and tyrosine by 
two E. coli auxotrophs. By regulating the expression of genes related to the export of 
tyrosine or production of tryptophan via inducible promoters, we were able to tune the 
metabolite exchanges and achieve a wide range of growth rates and strain ratios. We 
discovered that the burden of gene expression often outweighed the growth rate benefits 
conferred by the increased cross-feeding, so we adapted our model to capture the effect 
of inducing the export or synthesis proteins on the growth rate and/or strain “affinity” for 
the essential metabolite. 
In addition, by inverting the relationship of growth/ratio vs. inducer 
concentrations to create two-dimensional design space plots, we were able to “program” 
the co-culture in order to achieve desired outcomes.  This programmable proof-of-
concept circuit or its variants can be applied to more complex systems where precise 
tuning of the consortium would facilitate the optimization of specific objectives, such as 
increasing the overall efficiency of microbial production of biofuels or pharmaceuticals. 
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5.1.2 Engineering a two-member E. coli consortium for conversion of five- and six-
carbon sugars to isobutanol 
We have designed a two-member E. coli consortium that is capable of converting 
hexose monosaccharides and pentose mono- and oligosaccharides into isobutanol. We 
have shown that the co-culture of a five- and six-carbon specialist (NC5/NC6) produces 
higher titers of isobutanol than a diauxic strain (NC6) under the same conditions and also 
demonstrated that this co-culture grows well on AFEX-pretreated corn stover (CS) 
hydrolysate and produces almost up to ~3 g/L isobutanol (at ~65% of the theoretical 
yield) without supplementation (Figure 3.15). This work addresses some of the remaining 
challenges that remain in the conversion of lignocellulosic feedstocks to next-generation 
biofuels, such as complete utilization of five carbon sugars and achieving high titers on 
actual biomass substrates. Although we did not achieve as high of isobutanol titers as 
other studies, our yields are comparable or even higher in some cases. As discussed 
above we could possibly increase the titer by having more feeding cycles throughout the 
cultivation.  
It should also be noted that our main goal in this work was to design a system that 
can produce isobutanol on lignocellulosic biomass, not necessarily to produce the highest 
titers on defined laboratory media. Since our ultimate goal is to combine this NC5-NC6 
pair with a fungus to complete the consolidated bioprocessing (CBP) design (see Future 
Directions, Section 5.2.2), we were not as concerned with feeding cycles or additional 
supplementation and instead desired to mimic the eventual culture conditions when 
grown with a cellulolytic specialist. This is a different approach than in some previous 
studies, which focus first on biofuel production on defined media rather than on 
designing a robust process for use on lignocellulosic substrates. We feel that our two 
member consortium that has been proven to grow well on corn stover hydrolysate may 
prove to be more robust and adaptable than other production strains that may produce 
more isobutanol when grown on defined media. 
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5.1.3 Use of microbial consortia in high-throughput strain development for over-
production of L-valine and isobutanol  
In this work we designed a microbial detection system which will be utilized in 
sensing L-valine secretion from highly-secreting production strains. Secretor and sensor 
“proof-of-concept” strains were created and grown in co-culture on a microplate reader. 
While the pantothenate auxotroph and L-valine auxotroph were able to grow well in co-
culture, additional mutations meant to increase L-valine production may overshadow 
growth benefits conferred on this sensor strain. Although there was not an observed 
growth rate benefit from incorporating the ilvN feedback-resistant mutations, the ratio of 
the ΔilvE to EcLSBN strain increased to favor the sensor strain, ΔilvE, indicating 
possible increased L-valine secretion by strain EcLSBN. This preliminary result will be 
confirmed in future studies. 
5.2 Future directions 
5.2.1 Remove metabolic burden of the tunable circuit and application of the circuit 
in isobutanol production 
One issue with our tunable circuit is the fact that there was an obvious growth rate 
decrease due to the expression of the cross-feeding genes, which we termed the 
“metabolic burden”. A potential solution to this problem, discussed above, is to tune the 
genes on the chromosome rather than on a plasmid. Since YddG and TrpED are native E. 
coli proteins we could either change the promoter sequence of the chromosomal genes or 
move the entire cassette, including the tunable promoter, from the plasmid to the 
chromosome in another non-essential location, creating an extra copy of each gene. For 
TrpED it might be easier to do the latter, since we would also have to introduce the 
feedback-resistant mutation. These changes could be accomplished using the λRed 
recombination system (which would also need to be introduced into the cells) or via P1 
viral transduction. While this would likely decrease the burden of expression, it would 
also likely lessen the effect of the genes overall due to the changes in copy number, 
leading to a decrease in cross-feeding. In that case, we would need to optimize the 
inducer concentrations again in order to see the same effect. A possible benefit might be 
that the co-culture is more stable since there would be only one or two copies of the 
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cross-feeding genes. This would then decrease the time for the cultures to reach 
equilibrium, making the consortium easier to “program” and fit more in line with the 
original theoretical model. 
Second, an obvious future direction for the tunable circuit is to apply the circuit to 
production of a desired output, such as isobutanol. We have done extensive work to begin 
moving this system into the isobutanol producer JCL260 (61), however since we use 
yeast extract (YE) in our media (a common practice for bench-scale biofuel production) 
and since the hydrolysate contains amino acids (58), this rendered the circuit ineffective 
for our specific purposes. However, we could still use the circuit in this strain or the NV3 
strains in minimal media without YE, since this would be more industrially relevant and 
cheaper. We have continued to use YE so far since in microplate studies we observed that 
it supported the cells’ ability to grow in the presence of isobutanol (data not shown) and 
also led to increased isobutanol titers. If we were to get rid of this component we would 
likely see much lower titers unless we could utilize a more isobutanol-tolerant strain that 
has been optimized for growth without YE. As for growth on lignocellulosic biomass, we 
could try the circuit on a different feedstock that does not contain amino acids, or 
redesign the circuit to be based on cross-feeding nutrients that are not typically produced 
by plants. 
There is evidence that a tunable circuit would be useful in our co-utilization 
consortium; in differential plating tests the co-culture ratio at the end of the cultivation 
period sometimes favored the NC5 and sometimes favored the NC6, depending on the 
experiment and medium (Figure 3.14). As the co-utilization relationship is not 
mutualistic, one partner is free to outgrow the other and therefore is not a very stable 
interaction. Engineering a control system into the NC5/NC6 pair would ensure that both 
partners are present in the culture in the optimal ratio.  
5.2.2 Optimization of the isobutanol production system and incorporation into the 
multispecies consortium 
The two-member isobutanol consortium has room for further optimization with 
regard to several aspects of its design. As mentioned earlier, we observed much 
variability in isobutanol production, especially with the NC6 and NC5+NC6 cultures, 
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which may result from plasmid loss during the cultivation. Moving the plasmid-borne 
genes onto the chromosome may solve this issue but would also likely need further 
optimization as the chromosomal expression level will be much lower than the expression 
level from multi-copy plasmids. To increase our titers, we could scale up our process to a 
much larger reactor and could also incorporate a process for isobutanol removal, such as 
the gas stripping process (67) or distillation. As mentioned previously, as the toxicity 
limit of isobutanol is ~7-8 g/L an isobutanol removal system will need to be put in place 
in order to reach industrially relevant titers, which will also become more important as 
titers increase with the larger reactors. In our process the sugar was not completely 
consumed, so it is not clear that feeding cycles would increase titers with our current 
setup. More details on possible genetic improvements are given in the Discussion section 
of Chapter 3, above. 
As mentioned earlier, the ultimate end goal for the two-member E. coli 
consortium is to combine it with a cellulolytic fungus that can break down unhydrolyzed, 
pre-treated corn stover directly into fermentable sugars, skipping the costly enzymatic 
hydrolysis (Figure 5.1). Significant work has been done to optimize conditions for the 
growth of one bacterial C6 member and a fungus, Trichoderma reesei, which can 
hydrolyze cellulose and hemicellulose into mono- and oligosaccharides (99). T. reesei is 
an aerobic, mesophilic fungus that is often used in heterologous protein production as 
well as for commercial production of cellulases and hemicellulases due to its naturally 
cellulolytic nature (100, 101). The genome of T. reesei has also been sequenced (100), 
and tools for manipulating this fungus have been fairly well studied (101, 102) due to its 
utility in lignocellulosic biomass degradation. Since cellulose production by T. reesei is 
much more efficient under aerobic conditions than under anaerobic (103), we will likely 
continue this process under aerobic conditions unless we decide to switch to an anaerobic 
cellulose producer. 
The next step will be to combine the NC5/NC6 pair with either the pSA55/69 
plasmids or the pAK6/pSA69 plasmids with T. reesei to complete the conversion of corn 
stover into isobutanol in one reactor. Obviously, there will need to be significant 
optimization of co-culture conditions, however the work by another member of our 
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laboratory, Jeremy Minty, on the C6 and fungal co-culture will give us much background 
experience to hopefully expedite the optimization process (99). 
 
Figure 5.1 Multispecies consortium for isobutanol production. A T. reesei cellulolytic specialist breaks 
down the lignocellulosic biomass into pentose and glucose mono- and oligo-saccharides for the two 
bacterial specialists to ferment into isobutanol. 
5.2.3 Method for production strain development using a consortium-based HTS 
Finally, we would like to incorporate the secretor/sensor detection consortium 
into a larger system: a high-throughput method for overall production strain development 
and screening. A diagram of the entire process is shown in the previous chapter (Figure 
4.5). We will first create a mutant library employing such techniques as the recently-
developed genome manipulation technique Multiplex Automated Genome Engineering, 
or MAGE (84), to simultaneously and rapidly introduce various mutations throughout the 
secretor chromosome. This method, or similar methods, will allow us to simultaneously 
introduce numerous mutations (up to 30-40) over several rounds, thereby providing a 
unique examination of the combinatorial effects of some of the mutations that would not 
be otherwise observed. MAGE uses the same method of recombination as used to 



















recombination, so we can use the same base strain, EcHW24, with the PanB function 
removed. Instead of one oligo, however, a pool of oligos is mixed with the cells, and then 
multiple rounds of recombination are performed with the oligo pool, as well as 
enrichment steps, if desired (84). While this can be done by hand, recently the Church lab 
has been working on automating the system. This will then be much faster than 
incorporating the mutations one by one, leading to a high-throughput method for over-
producer construction and library generation. The resultant library of mutants will then, 
theoretically, secrete various levels of L-valine. The benefit of using a method such as 
MAGE, as opposed to evolution or completely rational design, is that various 
combinations of mutations can be studied, as opposed to only a final combination that 
results from evolution, or a chosen combination from rational design. We will use both 
rational design studies (64) and evolution experiments (63) to inform our oligo design for 
L-valine over-production. 
Next, the mutant library of secretors will be cultivated with the sensor strains in 
droplets on a microfluidic device. The device will allow us to isolate one pair per droplet, 
and, after cultivation, to sort the droplets by their level of growth or composition (i.e. 
fluorescence). The droplet generation and cultivation will take place on a microfluidic 
device developed for such purposes by Jihyang Park (104), and will then be harvested 
and sorted on another device that was under development previously by Jihyang and 
currently by Mathieu Rossion. Labview software will be used to sort the droplets based 
on the level of YFP expression from the sensor strain. 
Once the droplets are harvested and sorted, the strains can then be tested off-chip 
in flask experiments to confirm that those that have faster-growing pairs do indeed 
contain secretor strains that make more L-valine, and hopefully, isobutanol, once they are 
transformed with the relevant KDC- and ADH-containing plasmids. The secretors can 
then also be sequenced to determine which mutations they have incorporated. As 
mentioned in previous sections, we may want to switch to other plasmids for isobutanol 
production that have enzymes with higher activity, such as pSA65 (contains adhA, 66) 
instead of pSA55 (61). Additionally, since the pSA69 plasmid contains several genes 
from the valine synthesis pathway or homologues of these genes (such as alsS) we should 
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consider this when reincorporating the plasmids for isobutanol production. It is likely that 
several of these native genes will be mutated as a result of the MAGE process, so instead 
of using plasmid pSA69, the mutant genes (i.e. ilvIHCD) could be re-amplified from the 
E. coli chromosome if any are successfully mutated and then placed behind an inducible 
promoter. A similar effect of over-expressing genes and removing native regulation could 
also be accomplished by mutating the promoter region ahead of the genes using a 
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